<!DOCTYPE html>
<html lang="en">

  <head>
    <meta charset="utf-8">
    </meta>
    <title>Metadata reference</title>
  </head>

  <body>
    <h1>Metadata reference</h1>
    <div id="tocContainer">
      <ul>
        <li><a href="#package">Package ID</a></li>
        <li><a href="#dataSets">Data Sets</a></li>
        <li><a href="#dataElements">Data Elements</a></li>
        <li><a href="#dataElementGroups">Data Element Groups</a></li>
        <li><a href="#categoryCombos">Category Combos</a></li>
        <li><a href="#categories">Categories</a></li>
        <li><a href="#categoryOptions">Category Options</a></li>
        <li><a href="#categoryOptionCombos">Category Option Combos</a></li>
        <li><a href="#categoryOptionGroupSets">Category Option Group Sets</a></li>
        <li><a href="#categoryOptionGroups">Category Option Groups</a></li>
        <li><a href="#validationRules">Validation Rules</a></li>
        <li><a href="#validationRuleGroups">Validation Rule Groups</a></li>
        <li><a href="#predictorGroups">Predictor Groups</a></li>
        <li><a href="#predictors">Predictors</a></li>
        <li><a href="#indicatorGroups">Indicator Groups</a></li>
        <li><a href="#indicators">Indicators</a></li>
        <li><a href="#indicatorTypes">Indicator Types</a></li>
        <li><a href="#dashboards">Dashboards</a></li>
        <li><a href="#visualizations">Visualizations</a></li>
        <li><a href="#maps">Maps</a></li>
        <li><a href="#reports">Standard Reports</a></li>
        <li><a href="#legendSets">Legend Sets</a></li>
        <li><a href="#userGroups">User Groups</a></li>
      </ul>
    </div>
    <h2>Package info</h2>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Code</th>
        <td>TB</td>
      </tr>
      <tr>
        <th>Type</th>
        <td>AGGREGATE</td>
      </tr>
      <tr>
        <th>Version</th>
        <td>1.1.2</td>
      </tr>
      <tr>
        <th>DHIS2 version</th>
        <td>2.35.4</td>
      </tr>
      <tr>
        <th>DHIS2 build</th>
        <td>75e6655</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>20210625T044350</td>
      </tr>
      <tr>
        <th>Name</th>
        <td>TB_AGGREGATE_V1.1.2_2.35.4-en</td>
      </tr>
    </table>
    <h2 id="dataSets">Data sets</h2>
    <h3>[old records only] TB treatment outcomes - second line</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>[old records only] TB treatment outcomes - second line</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>No</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>Fn5XKDV6WRY</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>2021-02-08</td>
        <td>yUv5yI1pNyB</td>
      </tr>
      <tr>
        <td>Treatment outcome</td>
        <td>2021-02-08</td>
        <td>ugKixKY1GtG</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcome</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB)</td>
      </tr>
    </table>
    <h3>TB treatment outcomes - second line</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>TB treatment outcomes - second line</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>Gs0lVuq2APD</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-06-16</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>kiODgwGG9I2</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Second-line line treatment cohort</td>
        <td>2021-02-08</td>
        <td>IVifB7BrnKL</td>
      </tr>
      <tr>
        <td>Second-line treatment outcomes</td>
        <td>2021-02-08</td>
        <td>H972POT5R4v</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Second-line line treatment cohort</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Second-line line treatment cohort</td>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Second-line line treatment cohort</td>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Second-line treatment outcomes</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB)</td>
      </tr>
      <tr>
        <td>Second-line treatment outcomes</td>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB</td>
      </tr>
      <tr>
        <td>Second-line treatment outcomes</td>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB)</td>
      </tr>
    </table>
    <h3>TB treatment outcomes</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>TB treatment outcomes</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>OJKvp0HWVFA</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-06-16</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>lYNYevNTO7B</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>First-line treatment cohort</td>
        <td>2021-02-08</td>
        <td>cep1TdJsITG</td>
      </tr>
      <tr>
        <td>First-line treatment outcomes</td>
        <td>2021-02-08</td>
        <td>yjSqkH6WAzn</td>
      </tr>
      <tr>
        <td>HIV/TB activities</td>
        <td>2021-02-08</td>
        <td>H6Z5R5WUMVN</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>First-line treatment cohort</td>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>First-line treatment cohort</td>
        <td>TB - Outcomes: clinically diagnosed new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>First-line treatment cohort</td>
        <td>TB - Outcomes: previously treated (excluding relapse): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>First-line treatment cohort</td>
        <td>TB - Outcomes: HIV-positive TB, new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>First-line treatment outcomes</td>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse</td>
      </tr>
      <tr>
        <td>First-line treatment outcomes</td>
        <td>TB - Outcomes: clinically diagnosed new and relapse</td>
      </tr>
      <tr>
        <td>First-line treatment outcomes</td>
        <td>TB - Outcomes: previously treated (excluding relapse) </td>
      </tr>
      <tr>
        <td>First-line treatment outcomes</td>
        <td>TB - Outcomes: HIV-positive TB, new and relapse</td>
      </tr>
      <tr>
        <td>HIV/TB activities</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded (by time of outcome)</td>
      </tr>
      <tr>
        <td>HIV/TB activities</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded (by time of outcome)</td>
      </tr>
      <tr>
        <td>HIV/TB activities</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy (by time of outcome)</td>
      </tr>
      <tr>
        <td>HIV/TB activities</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART) (by time of outcome)</td>
      </tr>
    </table>
    <h3>TB case notification</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>TB case notification</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>lZA8cM2PbQk</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-06-16</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>OyutuMOPgkt</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>2021-02-08</td>
        <td>yqX51gJVt0Q</td>
      </tr>
      <tr>
        <td>New and relapse cases by age and sex</td>
        <td>2021-02-08</td>
        <td>d7cqFMypmvm</td>
      </tr>
      <tr>
        <td>Laboratory diagnostic activity</td>
        <td>2021-02-08</td>
        <td>cp9o2M4QlaW</td>
      </tr>
      <tr>
        <td>TB/HIV activities</td>
        <td>2021-02-08</td>
        <td>QASku0YuSAb</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - New pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - Relapsed pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - History unknown pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - New pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - Relapsed pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - History unknown pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - New extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - Relapsed extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - Previously treated (excluding relapse) extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed</td>
      </tr>
      <tr>
        <td>Cases registered</td>
        <td>TB - History unknown extrapulmonary TB cases bacteriologically confirmed or clinically diagnosed</td>
      </tr>
      <tr>
        <td>New and relapse cases by age and sex</td>
        <td>TB - New and relapse TB cases by age and sex</td>
      </tr>
      <tr>
        <td>Laboratory diagnostic activity</td>
        <td>TB - Presumptive TB cases bacteriologically tested</td>
      </tr>
      <tr>
        <td>Laboratory diagnostic activity</td>
        <td>TB - Presumptive TB cases bacteriologically tested positive</td>
      </tr>
      <tr>
        <td>TB/HIV activities</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB/HIV activities</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB/HIV activities</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
      </tr>
      <tr>
        <td>TB/HIV activities</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
      </tr>
    </table>
    <h3>TB RR/MDR-TB case detection and treatment</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>TB RR/MDR-TB case detection and treatment</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>iZLny8aqoGZ</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-06-16</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>rSfhnkAdm5y</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Case detection</td>
        <td>2021-02-08</td>
        <td>jv91EVFsUIB</td>
      </tr>
      <tr>
        <td>Treatment</td>
        <td>2021-02-08</td>
        <td>uY7DhCyqIAC</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Case detection</td>
        <td>TB - New TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>Case detection</td>
        <td>TB - Previously treated TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>Case detection</td>
        <td>TB - History unknown TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>Case detection</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases</td>
      </tr>
      <tr>
        <td>Case detection</td>
        <td>TB - Laboratory-confirmed MDR-TB cases </td>
      </tr>
      <tr>
        <td>Treatment</td>
        <td>TB - Patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>Treatment</td>
        <td>TB - Patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
      </tr>
    </table>
    <h3>TB Stock Report</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>TB Stock Report</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>No</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-03-30</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>ujLQPjUBfVR</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Opening balance</td>
        <td>2021-03-30</td>
        <td>C6xT0gWimdR</td>
      </tr>
      <tr>
        <td>Received</td>
        <td>2021-03-30</td>
        <td>VypF8MSdTWp</td>
      </tr>
      <tr>
        <td>Issued</td>
        <td>2021-06-11</td>
        <td>iZO1V1SK3Xu</td>
      </tr>
      <tr>
        <td>Redistributed</td>
        <td>2021-03-30</td>
        <td>q7q449DL3bP</td>
      </tr>
      <tr>
        <td>Discarded</td>
        <td>2021-03-30</td>
        <td>gB7IdC2fI8N</td>
      </tr>
      <tr>
        <td>Stock on hand</td>
        <td>2021-03-30</td>
        <td>Jogyq4eamOC</td>
      </tr>
      <tr>
        <td>Stock out days</td>
        <td>2021-03-30</td>
        <td>VImVGoso9eJ</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Opening balance</td>
        <td>TB - DR-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>Opening balance</td>
        <td>TB - DS-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>Opening balance</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
      </tr>
      <tr>
        <td>Received</td>
        <td>TB - DR-TB drugs received</td>
      </tr>
      <tr>
        <td>Received</td>
        <td>TB - DS-TB drugs received</td>
      </tr>
      <tr>
        <td>Received</td>
        <td>TB - GeneXpert Cartridges received</td>
      </tr>
      <tr>
        <td>Issued</td>
        <td>TB - DR-TB drugs issued</td>
      </tr>
      <tr>
        <td>Issued</td>
        <td>TB - DS-TB drugs issued</td>
      </tr>
      <tr>
        <td>Issued</td>
        <td>TB - GeneXpert Cartridges issued</td>
      </tr>
      <tr>
        <td>Redistributed</td>
        <td>TB - DR-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>Redistributed</td>
        <td>TB - DS-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>Redistributed</td>
        <td>TB - GeneXpert Cartridges redistributed</td>
      </tr>
      <tr>
        <td>Discarded</td>
        <td>TB - DR-TB drugs discarded</td>
      </tr>
      <tr>
        <td>Discarded</td>
        <td>TB - DS-TB drugs discarded</td>
      </tr>
      <tr>
        <td>Discarded</td>
        <td>TB - GeneXpert Cartridges discarded</td>
      </tr>
      <tr>
        <td>Stock on hand</td>
        <td>TB - DR-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>Stock on hand</td>
        <td>TB - DS-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>Stock on hand</td>
        <td>TB - GeneXpert Cartridges stock on hand</td>
      </tr>
      <tr>
        <td>Stock out days</td>
        <td>TB - DR-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>Stock out days</td>
        <td>TB - DS-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>Stock out days</td>
        <td>TB - GeneXpert Cartridges stock out days</td>
      </tr>
    </table>
    <h3>[old records only] TB treatment outcomes - by smear results</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>[old records only] TB treatment outcomes - by smear results</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>No</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>VQTEps77HLq</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>2021-02-08</td>
        <td>mgGpMO34jV6</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>2021-02-08</td>
        <td>W00qfXGbCg8</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: new pulmonary smear-positive (and/or culture positive): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: new pulmonary smear-negative and extrapulmonary (or smear unknown/not done): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: re-treatment: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-positive (and/or culture positive): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-negative and extrapulmonary (or smear unknown/not done): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcome cohort</td>
        <td>TB - Outcomes: TB/HIV re-treatment: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>TB - Outcomes: new pulmonary smear-positive (and/or culture positive)</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>TB - Outcomes: new pulmonary smear-negative and extrapulmonary (or smear unknown/not done)</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>TB - Outcomes: re-treatment</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-positive (and/or culture positive)</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-negative and extrapulmonary (or smear unknown/not done)</td>
      </tr>
      <tr>
        <td>Treatment outcomes</td>
        <td>TB - Outcomes: TB/HIV re-treatment</td>
      </tr>
    </table>
    <h3>[old records only] TB case registration by smear results</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>[old records only] TB case registration by smear results</td>
      </tr>
      <tr>
        <th>Custom form:</th>
        <td>No</td>
      </tr>
      <tr>
        <th>Sections:</th>
        <td>Yes</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID:</th>
        <td>Yhk4Ee59d9y</td>
      </tr>
    </table>
    <h4>Sections</h4>
    <table>
      <tr>
        <th>Section</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>2021-02-08</td>
        <td>REvRcB10Ooc</td>
      </tr>
      <tr>
        <td>Cases by sex and age (legacy)</td>
        <td>2021-02-08</td>
        <td>RrhBazcMtoa</td>
      </tr>
      <tr>
        <td>TB/HIV</td>
        <td>2021-02-08</td>
        <td>JSDyHzaslu5</td>
      </tr>
    </table>
    <h4>Data Set Section - Data Element</h4>
    <table>
      <tr>
        <th>Data Set Section</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - New pulmonary smear-positive</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - New pulmonary smear-negative</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - New pulmonary smear-unknown/not done</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - New extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - Other new cases</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - Relapse (pulmonary smear and/or culture-positive)</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - Treatment after failure (pulmonary smear and/or culture-positive)</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - Treatment after default (pulmonary smear and/or culture-positive)</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - Other re-treatment cases</td>
      </tr>
      <tr>
        <td>Cases by history</td>
        <td>TB - Other cases, history unknown</td>
      </tr>
      <tr>
        <td>Cases by sex and age (legacy)</td>
        <td>TB - New pulmonary smear-positive TB cases by age and sex</td>
      </tr>
      <tr>
        <td>Cases by sex and age (legacy)</td>
        <td>TB - New pulmonary smear-negative/smear-unknown/smear-not done TB cases by age and sex</td>
      </tr>
      <tr>
        <td>Cases by sex and age (legacy)</td>
        <td>TB - New extrapulmonary TB cases by age and sex</td>
      </tr>
      <tr>
        <td>TB/HIV</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB/HIV</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB/HIV</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
      </tr>
      <tr>
        <td>TB/HIV</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
      </tr>
    </table>
    <h2 id="dataElements">Data Elements</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Shortname</th>
        <th>Code</th>
        <th>Description</th>
        <th>Categorycombo</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TB - History unknown TB cases tested for rifampicin susceptibility</td>
        <td>Tested for R susceptibility, unknown history</td>
        <td>TB_RDST_UNK</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>aj8BY9VM5Eo</td>
      </tr>
      <tr>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-positive (and/or culture positive): cohort size (cases registered)</td>
        <td>Outcomes TB/HIV new smear+ cohort</td>
        <td>TB_HIV_NEW_SP_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>ayCq6H7Xx04</td>
      </tr>
      <tr>
        <td>TB - Previously treated TB cases tested for rifampicin susceptibility</td>
        <td>Tested for R susceptibility, previously treated</td>
        <td>TB_RDST_RET</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>b1bgx4QmS1I</td>
      </tr>
      <tr>
        <td>TB - Outcomes: TB/HIV re-treatment</td>
        <td>Outcomes TB/HIV re-treatment</td>
        <td>TB_HIV_RET</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>B2Gt4M7VXAe</td>
      </tr>
      <tr>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB)</td>
        <td>Outcomes RR-/MDR-TB</td>
        <td>TB_MDR</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>BXN41jBKb9c</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-negative/smear-unknown/smear-not done TB cases by age and sex</td>
        <td>New pulm smear- by age/sex</td>
        <td>TB_NEW_SN_</td>
        <td></td>
        <td>Age and sex (TB legacy)</td>
        <td>2021-02-08</td>
        <td>CN5QIF5zIj9</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges redistributed</td>
        <td>GeneXpert Cartridges redistributed</td>
        <td>TB_CARTRIDGE_REDISTRIBUTED</td>
        <td>Number of GeneXpert Cartridges redistributed back into the supply chain and is no longer intended for the patients of the reporting health facility</td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>cRNeiMflE2s</td>
      </tr>
      <tr>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-negative and extrapulmonary (or smear unknown/not done): cohort size (cases registered)</td>
        <td>Outcomes TB/HIV sm-/extrapulm cohort</td>
        <td>TB_HIV_NEW_SNEP_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>cUmPghsDVtZ</td>
      </tr>
      <tr>
        <td>TB - Patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
        <td>Unconf start MDR-TB treatment</td>
        <td>TB_UNCONF_RRMDR_TX</td>
        <td>Number of patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB. Include pulmonary and extrapulmonary TB and also patients diagnosed before the reporting period but started on treatment during the reporting period.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>cvGGWoMIk9y</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges stock out days</td>
        <td>GeneXpert Cartridges stock out days</td>
        <td>TB_CARTRIDGE_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of GeneXpert Cartridges (at any point during the day) during the reporting period. </td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>CxMUeg8LYid</td>
      </tr>
      <tr>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse: cohort size (cases registered)</td>
        <td>Outcomes labconf new relapse cohort</td>
        <td>TB_NEWREL_LABCONF_COH</td>
        <td>Number of bacteriologically confirmed cases registered. Excludes cases moved to second-line treatment.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>DcNF57mpVpN</td>
      </tr>
      <tr>
        <td>GEN - Population</td>
        <td>Population</td>
        <td>GEN_POP_NUM</td>
        <td>Total population</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>DkmMEcubiPv</td>
      </tr>
      <tr>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-positive (and/or culture positive)</td>
        <td>Outcomes TB/HIV new smear+</td>
        <td>TB_HIV_NEW_SP</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>dshydzA84xQ</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-positive TB cases by age and sex</td>
        <td>New pulm smear + by age/sex</td>
        <td>TB_NEW_SP_</td>
        <td></td>
        <td>Age and sex (TB legacy)</td>
        <td>2021-02-08</td>
        <td>EAFHfKsIwhz</td>
      </tr>
      <tr>
        <td>TB - History unknown pulmonary TB cases, clinically diagnosed</td>
        <td>Pulm clinically diagnosed, unknown history</td>
        <td>TB_OTH_CLINDX</td>
        <td>Treatment history unknown pulmonary TB cases, clinically diagnosed (Not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>EGlb6CP7czB</td>
      </tr>
      <tr>
        <td>TB - Outcomes: previously treated (excluding relapse): cohort size (cases registered)</td>
        <td>Outcomes previously treated, excl relapse cohort</td>
        <td>TB_RET_NREL_COH</td>
        <td>Number of cases registered. Excludes cases moved to second-line treatment.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>EIHWLztODGi</td>
      </tr>
      <tr>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded</td>
        <td>TB/HIV patients </td>
        <td>TB_HIVTEST_POS</td>
        <td>TB patients (new and relapse) notified during the year and had a POSITIVE HIV test result recorded in the TB register during the same year. This should include TB patients who were known to be HIV-positive before being diagnosed with TB.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>eO8nthpRoT4</td>
      </tr>
      <tr>
        <td>TB - Outcomes: new pulmonary smear-positive (and/or culture positive)</td>
        <td>Outcomes new smear+</td>
        <td>TB_NEW_SP_OUT</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>f8C78qtnw62</td>
      </tr>
      <tr>
        <td>TB - Facilities without GeneXpert cartridges stockout days reported</td>
        <td>HF without GeneXpert cartridges stockout days</td>
        <td>HF_WITHOUT_GENEXPERT_CARTRIDGES_STOCKOUT_DAYS</td>
        <td>This field is calculated by a predictor</td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>FH75MzJQA5u</td>
      </tr>
      <tr>
        <td>TB - TB patients (new and relapse) with HIV test result recorded</td>
        <td>TB patients tested for HIV</td>
        <td>TB_HIVTEST</td>
        <td>TB patients (new and relapse) notified during the year and had an HIV test result recorded in the TB register during the same year. This should include TB patients who were known to be HIV-positive before being diagnosed with TB, as well as TB patients with a negative HIV result from previous testing that was acceptable to the clinician (e.g. done in the last 3-6 months in a reliable laboratory).</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>FMLmCNm7QTf</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock out days</td>
        <td>DR-TB drugs stock out days</td>
        <td>TB_DRDRUGS_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of DR-TB drugs (at any point during the day) during the reporting period. </td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>fTKSvybB6Zh</td>
      </tr>
      <tr>
        <td>TB - Outcomes: re-treatment: cohort size (cases registered)</td>
        <td>Outcomes re-treatment cohort</td>
        <td>TB_RET_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>GSfpFjo9SL5</td>
      </tr>
      <tr>
        <td>TB - Relapse (pulmonary smear and/or culture-positive)</td>
        <td>Relapses</td>
        <td>TB_RET_REL</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>hKTgk1mG2qn</td>
      </tr>
      <tr>
        <td>TB - Outcomes: previously treated (excluding relapse) </td>
        <td>Outcomes previously treated, excl relapse</td>
        <td>TB_RET_NREL</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>HMvIu0dUfhe</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges stock on hand</td>
        <td>GeneXpert Cartridges stock on hand</td>
        <td>TB_CARTRIDGE_HAND</td>
        <td>Number of GeneXpert Cartridges on-hand at the facility after the physical stock count at the end of the reporting period</td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>iJYk0mA3H4I</td>
      </tr>
      <tr>
        <td>TB - Facilities with DR-TB drugs stockout days reported</td>
        <td>HF with DR-TB drugs stockout days reported</td>
        <td>HF_WITH_DR-TB_DRUGS_STOCKOUT_DAYS_REPORTED</td>
        <td>This field is calculated by a predictor</td>
        <td>default</td>
        <td>2021-02-18</td>
        <td>IyI7yOY6sXR</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges issued</td>
        <td>GeeXxpert cartridges issued</td>
        <td>TB_CARTRIDGE_ISSUED</td>
        <td>Number of GeneXpert cartridges issued to patients during the reporting period</td>
        <td>default</td>
        <td>2021-06-11</td>
        <td>J3AIrRG01TD</td>
      </tr>
      <tr>
        <td>TB - Outcomes: new pulmonary smear-positive (and/or culture positive): cohort size (cases registered)</td>
        <td>Outcomes new smear+ cohort</td>
        <td>TB_NEW_SP_OUT_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>JAB0n4ktBqu</td>
      </tr>
      <tr>
        <td>TB - Facilities with DS-TB drugs stockout days reported</td>
        <td>HF with DS-TB drugs stockout days reported</td>
        <td>HF_WITH_DS-TB_DRUGS_STOCKOUT_DAYS_REPORTED</td>
        <td>This field is calculated by a predictor</td>
        <td>default</td>
        <td>2021-02-18</td>
        <td>JbsaRc2nZsf</td>
      </tr>
      <tr>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases</td>
        <td>Lab-confirmed RR-/MDR-TB</td>
        <td>TB_CONF_RRMDR</td>
        <td>Number of laboratory-confirmed RR-TB or MDR-TB cases identified among all TB patients (pulmonary or extrapulmonary, new, previously treated, or unknown treatment history) using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF, line probe assay), before or after starting treatment</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>jbYbSDxfhtT</td>
      </tr>
      <tr>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB: cohort size (cases registered)</td>
        <td>Outcomes HIV+ RR-/MDR-TB cohort</td>
        <td>TB_HIVMDR_COH</td>
        <td>Number of HIV-positive RR-/MDR-TB cases registered.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>jL7xOEwVdDX</td>
      </tr>
      <tr>
        <td>TB - Outcomes: new pulmonary smear-negative and extrapulmonary (or smear unknown/not done): cohort size (cases registered)</td>
        <td>Outcomes new smear-/extrapulm cohort</td>
        <td>TB_NEW_SNEP_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>jP5Q6r8Wyrc</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs discarded</td>
        <td>DS-TB drugs discarded</td>
        <td>TB_DSDRUGS_DISCARDED</td>
        <td>Number of DS-TB drugs discarded during the reporting period (expired, damaged, etc.)</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>k2MTMQpheOh</td>
      </tr>
      <tr>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded (by time of outcome)</td>
        <td>TB/HIV patients at outcome</td>
        <td>TB_HIVTEST_POS_OUTC</td>
        <td>TB patients (new and relapse)  that had a POSITIVE HIV test result recorded in the TB register by the time the outcome was registered. This should include TB patients who were known to be HIV-positive before being diagnosed with TB.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>k6HZ0Z9zFer</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges received</td>
        <td>GeneXpert Cartridges received</td>
        <td>TB_CARTRIDGE_RECV</td>
        <td>Number of GeneXpert Cartridges received</td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>kfocuNP1nCG</td>
      </tr>
      <tr>
        <td>TB - Previously treated (excluding relapse) extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed</td>
        <td>Prev treated extrapulmonary</td>
        <td>TB_RET_NREL_EP</td>
        <td>Previously treated (excluding relapse) extrapulmonary cases. Cases with both pulmonary and extrapulmonary TB are classified as pulmonary TB cases.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>KhCB35MHs9A</td>
      </tr>
      <tr>
        <td>TB - Facilities with GeneXpert cartridges stockout days reported</td>
        <td>HF with GeneXpert cartridges stockout days</td>
        <td>HF_WITH_GENEXPERT_CARTRIDGES_STOCKOUT_DAYS</td>
        <td>This field is calculated by a predictor</td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>klUlIF1vgIg</td>
      </tr>
      <tr>
        <td>TB - Other re-treatment cases</td>
        <td>Other re-treatment</td>
        <td>TB_RET_OTH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>KZ7rMA7BqcQ</td>
      </tr>
      <tr>
        <td>TB - New extrapulmonary TB cases by age and sex</td>
        <td>New extrapulmonary by age/sex</td>
        <td>TB_NEW_EP_</td>
        <td></td>
        <td>Age and sex (TB legacy)</td>
        <td>2021-02-08</td>
        <td>l2YPwvUHjsS</td>
      </tr>
      <tr>
        <td>TB - Relapsed pulmonary TB cases, bacteriologically confirmed</td>
        <td>Relapse pulm bac confirmed</td>
        <td>TB_RET_REL_LABCONF</td>
        <td>Pulmonary TB cases, bacteriologically confirmed (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>l4TyT04yP8f</td>
      </tr>
      <tr>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-negative and extrapulmonary (or smear unknown/not done)</td>
        <td>Outcomes TB/HIV sm-/extrapulm</td>
        <td>TB_HIV_NEW_SNEP</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>LDNQRec9Bob</td>
      </tr>
      <tr>
        <td>TB - History unknown pulmonary TB cases, bacteriologically confirmed</td>
        <td>Pulmonary bac confirmed, unknown history</td>
        <td>TB_OTH_LABCONF</td>
        <td>Previous treatment history unknown pulmonary TB cases, bacteriologically confirmed (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>lgKh8oeoKVj</td>
      </tr>
      <tr>
        <td>TB - Facilities without DS-TB drugs stockout days reported</td>
        <td>HF without DS-TB drugs stockout days reported</td>
        <td>HF_WITHOUT_DS-TB_DRUGS_STOCKOUT_DAYS_REPORTED</td>
        <td>This field is calculated by a predictor</td>
        <td>default</td>
        <td>2021-02-18</td>
        <td>LqSBB96bJv0</td>
      </tr>
      <tr>
        <td>TB - Treatment after default (pulmonary smear and/or culture-positive)</td>
        <td>Treatment after default</td>
        <td>TB_RET_TAD</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>M6JHtLJJ34t</td>
      </tr>
      <tr>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB): cohort size (cases registered)</td>
        <td>Outcomes XDR-TB cohort</td>
        <td>TB_XDR_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>me7x7kaqWth</td>
      </tr>
      <tr>
        <td>TB - Presumptive TB cases bacteriologically tested positive</td>
        <td>Presumptive TB cases tested positive</td>
        <td>TB_PRESUMPTIVE_TESTPOS</td>
        <td>Data aggregated from the TB laboratory register based on Date specimen received, and excluding patients examined for follow-up.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>mG3LJzaZxb8</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs discarded</td>
        <td>DR-TB drugs discarded</td>
        <td>TB_DRDRUGS_DISCARDED</td>
        <td>Number of DR-TB drugs discarded during the reporting period (expired, damaged, etc.)</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>mMbufF9c251</td>
      </tr>
      <tr>
        <td>TB - Outcomes: clinically diagnosed new and relapse: cohort size (cases registered)</td>
        <td>Outcomes clindx new relapse cohort</td>
        <td>TB_NEWREL_CLINDX_COH</td>
        <td>Number of clinically diagnosed cases registered. Excludes cases moved to second-line treatment.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>mruHvHAumOI</td>
      </tr>
      <tr>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART) (by time of outcome)</td>
        <td>TB/HIV on ART at outcome</td>
        <td>TB_HIV_ART_OUTC</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>naqurivGjIK</td>
      </tr>
      <tr>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, clinically diagnosed</td>
        <td>Prev treated pulm clinically diagnosed</td>
        <td>TB_RET_NREL_CLINDX</td>
        <td>Previously treated (excluding relapse) pulmonary TB cases, clinically diagnosed (Not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>NJaeD9Xia7x</td>
      </tr>
      <tr>
        <td>TB - Patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
        <td>Conf start MDR-TB treatment</td>
        <td>TB_CONF_RRMDR_TX</td>
        <td>Number of patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB. Include pulmonary and extrapulmonary TB and also patients diagnosed before the reporting period but started on treatment during the reporting period.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>NmVXzjN0SPM</td>
      </tr>
      <tr>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse</td>
        <td>Outcomes labconf new relapse</td>
        <td>TB_NEWREL_LABCONF</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>Ns5mfRqKAe3</td>
      </tr>
      <tr>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, bacteriologically confirmed</td>
        <td>Prev treated pulm bac confirmed</td>
        <td>TB_RET_NREL_LABCONF</td>
        <td>Previously treated (excluding relapses) pulmonary TB cases, bacteriologically confirmed (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>Nv1RGi4eI7F</td>
      </tr>
      <tr>
        <td>TB - Relapsed pulmonary TB cases, clinically diagnosed</td>
        <td>Relapse pulm clinic diagnosed</td>
        <td>TB_RET_REL_CLINDX</td>
        <td>Pulmonary TB cases, clinically diagnosed (Not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>NYxehRdsQx3</td>
      </tr>
      <tr>
        <td>TB - Outcomes: HIV-positive TB, new and relapse</td>
        <td>Outcomes TB/HIV new and relapse</td>
        <td>TB_TBHIV</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>oJ4x8PXZvnh</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs received</td>
        <td>DS-TB drugs received</td>
        <td>TB_DSDRUGS_RECV</td>
        <td>Number of DS-TB drugs received</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>oMvma7tGHrq</td>
      </tr>
      <tr>
        <td>TB - Facilities without DR-TB drugs stockout days reported</td>
        <td>HF without DR-TB drugs stockout days reported</td>
        <td>HF_WITHOUT_DR-TB_DRUGS_STOCKOUT_DAYS_REPORTED</td>
        <td>This field is calculated by a predictor</td>
        <td>default</td>
        <td>2021-02-18</td>
        <td>OP3WSRBX504</td>
      </tr>
      <tr>
        <td>TB - New pulmonary TB cases, bacteriologically confirmed</td>
        <td>New pulm bac confirmed</td>
        <td>TB_NEW_LABCONF</td>
        <td>Pulmonary TB cases, bacteriologically confirmed (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>Orjo9ewlU9Z</td>
      </tr>
      <tr>
        <td>TB - Treatment after failure (pulmonary smear and/or culture-positive)</td>
        <td>Treatment after failure</td>
        <td>TB_RET_TAF</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>PdhQ1JCS2ij</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs opening balance</td>
        <td>DS-TB drugs opening balance</td>
        <td>TB_DSDRUGS_OPENING_BALANCE</td>
        <td>The opening balance equals the physical 'stock on hand count' from prior month; this data element carried over the value from the previous month. It is prepopulated in the data entry form by carrying over the previous month's value and does need to be entered by the user. </td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>PNhNeVxy9Bs</td>
      </tr>
      <tr>
        <td>TB - Other cases, history unknown</td>
        <td>Others (e.g. history unknown)</td>
        <td>TB_NEWRET_OTH</td>
        <td>Other cases with unknown history</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>PRB6dolaxC4</td>
      </tr>
      <tr>
        <td>TB - History unknown extrapulmonary TB cases bacteriologically confirmed or clinically diagnosed</td>
        <td>Extrapulmonary, unknown history </td>
        <td>TB_OTH_EP</td>
        <td>Previous treatment history unknown extrapulmonary cases. Cases with both pulmonary and extrapulmonary TB are classified as pulmonary TB cases.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>Q5KSbP9ZzHQ</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs issued</td>
        <td>DS-TB drugs issued </td>
        <td>TB_DSDRUGS_ISSUED</td>
        <td>Number of DS-TB drugs issued to patients during the reporting period</td>
        <td>default</td>
        <td>2021-06-11</td>
        <td>QH1eMVEVhpn</td>
      </tr>
      <tr>
        <td>TB - New pulmonary TB cases, clinically diagnosed</td>
        <td>New pulm clinically diagnosed</td>
        <td>TB_NEW_CLINDX</td>
        <td>Pulmonary TB cases, clinically diagnosed (Not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment)</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>qlkxnlC6dzU</td>
      </tr>
      <tr>
        <td>TB - New TB cases tested for rifampicin susceptibility</td>
        <td>Tested for R susceptibility, new cases</td>
        <td>TB_RDST_NEW</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>QMGQTTJAiMu</td>
      </tr>
      <tr>
        <td>TB - Relapsed extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
        <td>Relapse extrapulmonary</td>
        <td>TB_RET_REL_EP</td>
        <td>Cases with both pulmonary and extrapulmonary TB are classified as pulmonary TB cases</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>QNFhsj0fOxK</td>
      </tr>
      <tr>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
        <td>TB/HIV on ART</td>
        <td>TB_HIV_ART</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>QStu7Ux1Loa</td>
      </tr>
      <tr>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB</td>
        <td>Outcomes HIV+ RR-/MDR-TB</td>
        <td>TB_HIVMDR</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>quUtGfLgolX</td>
      </tr>
      <tr>
        <td>TB - Laboratory-confirmed MDR-TB cases </td>
        <td>Lab-confirmed MDR-TB</td>
        <td>TB_CONF_MDR</td>
        <td>Number of laboratory-confirmed MDR-TB cases identified among all TB patients (pulmonary or extrapulmonary, new, previously treated, or unknown treatment history) using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF, line probe assay), before or after starting treatment</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>qwL7Tq9rROF</td>
      </tr>
      <tr>
        <td>TB - Outcomes: re-treatment</td>
        <td>Outcomes re-treatment</td>
        <td>TB_RET</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>rdG3GMhWbDn</td>
      </tr>
      <tr>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB): cohort size (cases registered)</td>
        <td>Outcomes RR-/MDR-TB cohort</td>
        <td>TB_MDR_COH</td>
        <td>Number of cases registered. Excludes cases moved to second-line treatment.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>rqe6qIBHEJr</td>
      </tr>
      <tr>
        <td>TB - Outcomes: clinically diagnosed new and relapse</td>
        <td>Outcomes clindx new relapse</td>
        <td>TB_NEWREL_CLINDX</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>s2OAugtcXPM</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs received</td>
        <td>DR-TB drugs received</td>
        <td>TB_DRDRUGS_RECV</td>
        <td>Number of DR-TB drugs received</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>ShJ42zyXevh</td>
      </tr>
      <tr>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
        <td>TB/HIV on CPT</td>
        <td>TB_HIV_CPT</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>sJRCCgJJBHD</td>
      </tr>
      <tr>
        <td>TB - Outcomes: TB/HIV re-treatment: cohort size (cases registered)</td>
        <td>Outcomes TB/HIV re-treatment cohort</td>
        <td>TB_HIV_RET_COH</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>sYxpz85N7ND</td>
      </tr>
      <tr>
        <td>TB - Outcomes: new pulmonary smear-negative and extrapulmonary (or smear unknown/not done)</td>
        <td>Outcomes new smear-/extrapulm</td>
        <td>TB_NEW_SNEP</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>TAfRi0DW7wn</td>
      </tr>
      <tr>
        <td>TB - Presumptive TB cases bacteriologically tested</td>
        <td>Presumptive TB cases tested</td>
        <td>TB_PRESUMPTIVE_TEST</td>
        <td>Data aggregated from the TB laboratory register based on Date specimen received, and excluding patients examined for follow-up</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>tl9LwbDa3ny</td>
      </tr>
      <tr>
        <td>TB - New and relapse TB cases by age and sex</td>
        <td>New relapse by age/sex</td>
        <td>TB_NEWREL</td>
        <td>New and relapse TB cases, including pulmonary or extrapulmonary, bacteriologically confirmed or clinically diagnosed</td>
        <td>Age and sex (TB)</td>
        <td>2021-02-08</td>
        <td>tr0lVojK425</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock out days</td>
        <td>DS-TB drugs stock out days</td>
        <td>TB_DSDRUGS_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of DS-TB drugs (at any point during the day) during the reporting period. </td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>tZuKlwig9lD</td>
      </tr>
      <tr>
        <td>TB - TB patients (new and relapse) with HIV test result recorded (by time of outcome)</td>
        <td>TB patients tested for HIV at outcome</td>
        <td>TB_HIVTEST_OUTC</td>
        <td>TB patients (new and relapse) that had an HIV test result recorded in the TB register by the time the outcome was registered. This should include TB patients who were known to be HIV-positive before being diagnosed with TB, as well as TB patients with a negative HIV result from previous testing that was acceptable to the clinician (e.g. done in the last 3-6 months in a reliable laboratory).</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>URwo7ZKQilR</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock on hand</td>
        <td>DS-TB drugs stock on hand</td>
        <td>TB_DSDRUGS_HAND</td>
        <td>Number of DS-TB drugs on-hand at the facility after the physical stock count at the end of the reporting period</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>uXt7OH5811r</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-unknown/not done</td>
        <td>New pulmonary smear unknown</td>
        <td>TB_NEW_SU</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>v2qRhkUmjlV</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs opening balance</td>
        <td>DR-TB drugs opening balance</td>
        <td>TB_DRDRUGS_OPENING_BALANCE</td>
        <td>The opening balance equals the physical 'stock on hand count' from prior month; this data element carried over the value from the previous month. It is prepopulated in the data entry form by carrying over the previous month's value and does need to be entered by the user. </td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>V7rRkP7jYzO</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-negative</td>
        <td>New pulmonary smear -</td>
        <td>TB_NEW_SN</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>voLCYElGAjX</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-positive</td>
        <td>New pulmonary smear +</td>
        <td>TB_NEW_SP</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>wadYJEcT9yh</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs redistributed</td>
        <td>DS-TB drugs redistributed</td>
        <td>TB_DSDRUGS_REDISTRIBUTED</td>
        <td>Number of DS-TB drugs redistributed back into the supply chain and is no longer intended for the patients of the reporting health facility</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>Wl9HUMqAXhQ</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs redistributed</td>
        <td>DR-TB drugs redistributed</td>
        <td>TB_DRDRUGS_REDISTRIBUTED</td>
        <td>Number of DR-TB drugs redistributed back into the supply chain and is no longer intended for the patients of the reporting health facility</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>wMv5SrxZ7f6</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock on hand</td>
        <td>DR-TB drugs stock on hand </td>
        <td>TB_DRDRUGS_HAND</td>
        <td>Number of DR-TB drugs on-hand at the facility after the physical stock count at the end of the reporting period</td>
        <td>default</td>
        <td>2020-12-16</td>
        <td>WOStFrYxPd9</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges opening balance</td>
        <td>GeneXpert Cartridges opening balance</td>
        <td>TB_CARTRIDGE_OPENING_BALANCE</td>
        <td>The opening balance equals the physical 'stock on hand count' from prior month; this data element carried over the value from the previous month. It is prepopulated in the data entry form by carrying over the previous month's value and does need to be entered by the user. </td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>wqihyXhQuK9</td>
      </tr>
      <tr>
        <td>TB - Other new cases</td>
        <td>Other new cases</td>
        <td>TB_NEW_OTH</td>
        <td>Other new cases not classified as new pulmonary or new extrapulmonary</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>XLV3S8QL8jV</td>
      </tr>
      <tr>
        <td>TB - GeneXpert Cartridges discarded</td>
        <td>GeneXpert Cartridges discarded</td>
        <td>TB_CARTRIDGE_DISCARDED</td>
        <td>Number of GeneXpert Cartridges discarded during the reporting period (expired, damaged, etc.)</td>
        <td>default</td>
        <td>2021-03-02</td>
        <td>y2yiFi6D7yY</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs issued</td>
        <td>DR-TB drugs issued</td>
        <td>TB_DRDRUGS_ISSUED</td>
        <td>Number of DR-TB drugs issued to patients during the reporting period</td>
        <td>default</td>
        <td>2021-06-11</td>
        <td>Z5hsBAh8pCC</td>
      </tr>
      <tr>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB)</td>
        <td>Outcomes XDR-TB</td>
        <td>TB_XDR</td>
        <td></td>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>zgrK8yB9Tsp</td>
      </tr>
      <tr>
        <td>TB - New extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
        <td>New extrapulmonary</td>
        <td>TB_NEW_EP</td>
        <td>Cases with both pulmonary and extrapulmonary TB are classified as pulmonary TB cases</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>ZiF0ngznP1Z</td>
      </tr>
      <tr>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy (by time of outcome)</td>
        <td>TB/HIV on CPT at outcome</td>
        <td>TB_HIV_CPT_OUTC</td>
        <td></td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>ZoqWQikYpwx</td>
      </tr>
      <tr>
        <td>TB - Outcomes: HIV-positive TB, new and relapse: cohort size (cases registered)</td>
        <td>Outcomes TB/HIV new and relapse cohort</td>
        <td>TB_TBHIV_COH</td>
        <td>Number of cases registered. Excludes cases moved to second-line treatment.</td>
        <td>default</td>
        <td>2021-02-08</td>
        <td>ZpJNlVE95GS</td>
      </tr>
    </table>
    <h2>Data Element Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Shortname</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB treatment outcomes - second line</td>
        <td>2021-02-08</td>
        <td>aGtzAAao0Mt</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB case notification</td>
        <td>2021-02-08</td>
        <td>fAS1m0weZsf</td>
      </tr>
      <tr>
        <td>Population estimates</td>
        <td>Population estimates</td>
        <td>2021-02-08</td>
        <td>gDwHOp9bAdJ</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB treatment outcomes</td>
        <td>2021-02-08</td>
        <td>m54T3OptLaU</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB RR/MDR</td>
        <td>2021-02-08</td>
        <td>V4Ctf7L4wq6</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB</td>
        <td>2021-02-08</td>
        <td>VGJHJGsfdRR</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB stock</td>
        <td>2021-02-18</td>
        <td>vkLzv5SqH4a</td>
      </tr>
    </table>
    <h3>Data Element Groups - Data Elements</h3>
    <table>
      <tr>
        <th>Data Element Group</th>
        <th>Data Element</th>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB</td>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes - second line</td>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB)</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - History unknown pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Previously treated (excluding relapse) extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Relapsed pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - History unknown pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Presumptive TB cases bacteriologically tested positive</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Relapsed pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - New pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - History unknown extrapulmonary TB cases bacteriologically confirmed or clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - New pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Relapsed extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - Presumptive TB cases bacteriologically tested</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - New and relapse TB cases by age and sex</td>
      </tr>
      <tr>
        <td>TB case registration</td>
        <td>TB - New extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>Population estimates</td>
        <td>GEN - Population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: previously treated (excluding relapse): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: previously treated (excluding relapse) </td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: clinically diagnosed new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART) (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: HIV-positive TB, new and relapse</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: clinically diagnosed new and relapse</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Outcomes: HIV-positive TB, new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - History unknown TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Previously treated TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - New TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed MDR-TB cases </td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - History unknown TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-positive (and/or culture positive): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Previously treated TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: TB/HIV re-treatment</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary smear-negative/smear-unknown/smear-not done TB cases by age and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-negative and extrapulmonary (or smear unknown/not done): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-positive (and/or culture positive)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary smear-positive TB cases by age and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - History unknown pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: previously treated (excluding relapse): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: new pulmonary smear-positive (and/or culture positive)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: re-treatment: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Relapse (pulmonary smear and/or culture-positive)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: previously treated (excluding relapse) </td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: new pulmonary smear-positive (and/or culture positive): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: new pulmonary smear-negative and extrapulmonary (or smear unknown/not done): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB patients (new and relapse) with positive HIV test result recorded (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Previously treated (excluding relapse) extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Other re-treatment cases</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New extrapulmonary TB cases by age and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Relapsed pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: TB/HIV new pulmonary smear-negative and extrapulmonary (or smear unknown/not done)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - History unknown pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Treatment after default (pulmonary smear and/or culture-positive)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Presumptive TB cases bacteriologically tested positive</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: clinically diagnosed new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART) (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: bacteriologically confirmed new and relapse</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Previously treated (excluding relapse) pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Relapsed pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: HIV-positive TB, new and relapse</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary TB cases, bacteriologically confirmed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Treatment after failure (pulmonary smear and/or culture-positive)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Other cases, history unknown</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - History unknown extrapulmonary TB cases bacteriologically confirmed or clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary TB cases, clinically diagnosed</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New TB cases tested for rifampicin susceptibility</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Relapsed extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: HIV-positive cases of RR-/MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed MDR-TB cases </td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: re-treatment</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: confirmed cases of rifampicin-resistant TB (RR-/MDR-TB): cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: clinically diagnosed new and relapse</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: TB/HIV re-treatment: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: new pulmonary smear-negative and extrapulmonary (or smear unknown/not done)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Presumptive TB cases bacteriologically tested</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New and relapse TB cases by age and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB patients (new and relapse) with HIV test result recorded (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary smear-unknown/not done</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary smear-negative</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New pulmonary smear-positive</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Other new cases</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: confirmed cases of extensively drug-resistant TB (XDR-TB)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - New extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed </td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - HIV-positive TB patients started/continued co-trimoxazole preventive therapy (by time of outcome)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Outcomes: HIV-positive TB, new and relapse: cohort size (cases registered)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Facilities without GeneXpert cartridges stockout days reported</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Facilities with DR-TB drugs stockout days reported</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Facilities with DS-TB drugs stockout days reported</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Facilities with GeneXpert cartridges stockout days reported</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Facilities without DS-TB drugs stockout days reported</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Facilities without DR-TB drugs stockout days reported</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs issued</td>
      </tr>
    </table>
    <h2 id="categoryCombos">Category Combinations</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
        <th>Categories</th>
      </tr>
      <tr>
        <td>default</td>
        <td>2021-02-08</td>
        <td>bjDvmb4bfuf</td>
        <td>default</td>
      </tr>
      <tr>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>mYvRBhu9rSh</td>
        <td>TB treatment outcome</td>
      </tr>
      <tr>
        <td>Age and sex (TB legacy)</td>
        <td>2021-02-08</td>
        <td>nzDu4irK6GP</td>
        <td>Sex (with unknown); Age (TB legacy)</td>
      </tr>
      <tr>
        <td>Age and sex (TB)</td>
        <td>2021-02-08</td>
        <td>Ow8ltIsRQKX</td>
        <td>Age (TB); Sex</td>
      </tr>
    </table>
    <h2 id="categories">Data Element Categories</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
        <th>Category options</th>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>2021-02-08</td>
        <td>b7peexUktxt</td>
        <td>Male; Female; Unknown Sex</td>
      </tr>
      <tr>
        <td>Age (TB legacy)</td>
        <td>2021-02-08</td>
        <td>FoUE8OoKd3a</td>
        <td>0-4 years; 5-14 years; 0-14 years; 15-24 years; 25-34 years; 35-44 years; 45-54 years; 55-64 years; 65+ years; Unknown Age; 15+ years</td>
      </tr>
      <tr>
        <td>Sex</td>
        <td>2021-02-08</td>
        <td>FRwO58KwwJt</td>
        <td>Male; Female</td>
      </tr>
      <tr>
        <td>default</td>
        <td>2021-06-25</td>
        <td>GLevLNI9wkl</td>
        <td>default</td>
      </tr>
      <tr>
        <td>TB treatment outcome</td>
        <td>2021-02-08</td>
        <td>NJqLkTLUyQw</td>
        <td>Cured; Completed; Died; Failed; Lost to follow up; Not evaluated</td>
      </tr>
      <tr>
        <td>Age (TB)</td>
        <td>2021-02-08</td>
        <td>Q3xIIv2LDJF</td>
        <td>0-4 years; 5-14 years; 15-24 years; 25-34 years; 35-44 years; 45-54 years; 55-64 years; 65+ years; Unknown Age</td>
      </tr>
    </table>
    <h2 id="categoryOptions">Data Element Category Options</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Cured</td>
        <td>2021-02-08</td>
        <td>eJQzEe4Ih1J</td>
      </tr>
      <tr>
        <td>Female</td>
        <td>2021-03-22</td>
        <td>FFA9e1yIXCT</td>
      </tr>
      <tr>
        <td>Failed</td>
        <td>2021-02-08</td>
        <td>H13RnX01yi8</td>
      </tr>
      <tr>
        <td>0-14 years</td>
        <td>2021-05-03</td>
        <td>IoqDBYr0rH5</td>
      </tr>
      <tr>
        <td>Died</td>
        <td>2021-02-08</td>
        <td>kPLC2WWJfZl</td>
      </tr>
      <tr>
        <td>Unknown Sex</td>
        <td>2021-03-22</td>
        <td>kuP5EmQRFke</td>
      </tr>
      <tr>
        <td>55-64 years</td>
        <td>2021-02-08</td>
        <td>Lo1gxiS8zap</td>
      </tr>
      <tr>
        <td>15-24 years</td>
        <td>2021-02-08</td>
        <td>ls9vGYWbvwG</td>
      </tr>
      <tr>
        <td>Male</td>
        <td>2021-03-22</td>
        <td>MP15bHaQh2x</td>
      </tr>
      <tr>
        <td>45-54 years</td>
        <td>2021-02-08</td>
        <td>nkQw9lhkbGV</td>
      </tr>
      <tr>
        <td>25-34 years</td>
        <td>2021-02-08</td>
        <td>O6UJSfL4psp</td>
      </tr>
      <tr>
        <td>65+ years</td>
        <td>2021-02-08</td>
        <td>OGo8Nqa4e6V</td>
      </tr>
      <tr>
        <td>Not evaluated</td>
        <td>2021-02-08</td>
        <td>oi6VWhss3oi</td>
      </tr>
      <tr>
        <td>5-14 years</td>
        <td>2021-02-08</td>
        <td>pa0cY66MrG6</td>
      </tr>
      <tr>
        <td>Completed</td>
        <td>2021-02-08</td>
        <td>tAzEtOUp7bB</td>
      </tr>
      <tr>
        <td>0-4 years</td>
        <td>2021-05-04</td>
        <td>UPvKbcqTEY3</td>
      </tr>
      <tr>
        <td>35-44 years</td>
        <td>2021-02-08</td>
        <td>utyLRFta4ie</td>
      </tr>
      <tr>
        <td>Unknown Age</td>
        <td>2021-03-22</td>
        <td>WNPpyVkVaL3</td>
      </tr>
      <tr>
        <td>15+ years</td>
        <td>2021-02-08</td>
        <td>wTpH7wugXzZ</td>
      </tr>
      <tr>
        <td>default</td>
        <td>2021-02-08</td>
        <td>xYerKDKCefk</td>
      </tr>
      <tr>
        <td>Lost to follow up</td>
        <td>2021-02-08</td>
        <td>YU7zBJ1rNnI</td>
      </tr>
    </table>
    <h2 id="categoryOptionCombos">Category Option Combination</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Unknown Sex, 15+ years</td>
        <td>2020-06-22</td>
        <td>a72PMVLM7y3</td>
      </tr>
      <tr>
        <td>Male, 0-4 years</td>
        <td>2021-02-08</td>
        <td>ahgn5DHCw1M</td>
      </tr>
      <tr>
        <td>Unknown Sex, 0-14 years</td>
        <td>2020-06-22</td>
        <td>b9rb6qpqgO9</td>
      </tr>
      <tr>
        <td>Female, 65+ years</td>
        <td>2021-02-08</td>
        <td>bhS8lXg8ssx</td>
      </tr>
      <tr>
        <td>Male, 0-14 years</td>
        <td>2021-02-08</td>
        <td>Buv6Vt7rlaN</td>
      </tr>
      <tr>
        <td>Lost to follow up</td>
        <td>2021-02-08</td>
        <td>DMLDJKLx3TG</td>
      </tr>
      <tr>
        <td>Male, 25-34 years</td>
        <td>2021-02-08</td>
        <td>F0DxP1DUjXH</td>
      </tr>
      <tr>
        <td>Male, Unknown Age</td>
        <td>2020-06-22</td>
        <td>FaLnUSglZDP</td>
      </tr>
      <tr>
        <td>15-24 years, Male</td>
        <td>2021-02-08</td>
        <td>fGPIkhFU9gZ</td>
      </tr>
      <tr>
        <td>Female, 55-64 years</td>
        <td>2021-02-08</td>
        <td>fP0kAy95WOI</td>
      </tr>
      <tr>
        <td>0-4 years, Female</td>
        <td>2021-02-08</td>
        <td>fQ59eeXTE19</td>
      </tr>
      <tr>
        <td>Female, 15-24 years</td>
        <td>2021-02-08</td>
        <td>GXkDk7Qq8mG</td>
      </tr>
      <tr>
        <td>default</td>
        <td>2021-02-08</td>
        <td>HllvX50cXC0</td>
      </tr>
      <tr>
        <td>Female, 0-14 years</td>
        <td>2021-02-08</td>
        <td>hrPYhzRokAX</td>
      </tr>
      <tr>
        <td>35-44 years, Female</td>
        <td>2021-02-08</td>
        <td>hTTSLrG15qa</td>
      </tr>
      <tr>
        <td>Completed</td>
        <td>2021-02-08</td>
        <td>iM0qxBnikZu</td>
      </tr>
      <tr>
        <td>Not evaluated</td>
        <td>2021-02-08</td>
        <td>J2cbgmrJBwc</td>
      </tr>
      <tr>
        <td>Male, 55-64 years</td>
        <td>2021-02-08</td>
        <td>j6dSWJ3QikR</td>
      </tr>
      <tr>
        <td>Male, 15+ years</td>
        <td>2021-02-08</td>
        <td>JPko43UMgN4</td>
      </tr>
      <tr>
        <td>Cured</td>
        <td>2021-02-08</td>
        <td>jYWVH1TpZhO</td>
      </tr>
      <tr>
        <td>Unknown Sex, 35-44 years</td>
        <td>2020-06-22</td>
        <td>Kh1iW9k7mkS</td>
      </tr>
      <tr>
        <td>Unknown Sex, 55-64 years</td>
        <td>2020-06-22</td>
        <td>KSHCuyPcm5E</td>
      </tr>
      <tr>
        <td>65+ years, Male</td>
        <td>2021-02-08</td>
        <td>KuHpVjsOQKx</td>
      </tr>
      <tr>
        <td>55-64 years, Female</td>
        <td>2021-02-08</td>
        <td>LKgmRuovjop</td>
      </tr>
      <tr>
        <td>Male, 65+ years</td>
        <td>2021-02-08</td>
        <td>LQQMOZTyZmD</td>
      </tr>
      <tr>
        <td>65+ years, Female</td>
        <td>2021-02-08</td>
        <td>MCWLRNrBBOq</td>
      </tr>
      <tr>
        <td>Male, 35-44 years</td>
        <td>2021-02-08</td>
        <td>nosZSeJC3Gl</td>
      </tr>
      <tr>
        <td>Unknown Sex, 0-4 years</td>
        <td>2020-06-22</td>
        <td>Nu5DUxw6f6n</td>
      </tr>
      <tr>
        <td>Unknown Sex, 45-54 years</td>
        <td>2020-06-22</td>
        <td>NXkmu9yIKb5</td>
      </tr>
      <tr>
        <td>Female, 45-54 years</td>
        <td>2021-02-08</td>
        <td>nYKWbW4JvkC</td>
      </tr>
      <tr>
        <td>Female, 0-4 years</td>
        <td>2021-02-08</td>
        <td>oPiYwMFcq1r</td>
      </tr>
      <tr>
        <td>Male, 45-54 years</td>
        <td>2021-02-08</td>
        <td>ox4ZRileubR</td>
      </tr>
      <tr>
        <td>Female, Unknown Age</td>
        <td>2020-06-22</td>
        <td>OynTkhmy135</td>
      </tr>
      <tr>
        <td>0-4 years, Male</td>
        <td>2021-02-08</td>
        <td>PcXvX2I0Z1b</td>
      </tr>
      <tr>
        <td>Female, 5-14 years</td>
        <td>2021-02-08</td>
        <td>PEaQ7efLnLb</td>
      </tr>
      <tr>
        <td>35-44 years, Male</td>
        <td>2021-02-08</td>
        <td>PwBF9kiGSTp</td>
      </tr>
      <tr>
        <td>15-24 years, Female</td>
        <td>2021-02-08</td>
        <td>PWh3RWTZSRH</td>
      </tr>
      <tr>
        <td>45-54 years, Male</td>
        <td>2021-02-08</td>
        <td>qFz7OICuv0Z</td>
      </tr>
      <tr>
        <td>5-14 years, Female</td>
        <td>2021-02-08</td>
        <td>rDzmnH2ECiL</td>
      </tr>
      <tr>
        <td>Unknown Sex, 65+ years</td>
        <td>2021-02-08</td>
        <td>RY3Fqxb0Fnf</td>
      </tr>
      <tr>
        <td>Female, 15+ years</td>
        <td>2021-02-08</td>
        <td>sdgaBKAPl7j</td>
      </tr>
      <tr>
        <td>45-54 years, Female</td>
        <td>2021-02-08</td>
        <td>t9r0WNolYN2</td>
      </tr>
      <tr>
        <td>Unknown Sex, 15-24 years</td>
        <td>2020-06-22</td>
        <td>TnSTISB7toD</td>
      </tr>
      <tr>
        <td>Failed</td>
        <td>2021-02-08</td>
        <td>U8hYpF6jgJr</td>
      </tr>
      <tr>
        <td>25-34 years, Male</td>
        <td>2021-02-08</td>
        <td>UdKHt4kcT0M</td>
      </tr>
      <tr>
        <td>Male, 15-24 years</td>
        <td>2021-02-08</td>
        <td>vblxXtbDltI</td>
      </tr>
      <tr>
        <td>Died</td>
        <td>2021-02-08</td>
        <td>vws5Iw9WoXo</td>
      </tr>
      <tr>
        <td>Unknown Age, Male</td>
        <td>2020-06-22</td>
        <td>WrTcXFoa5TX</td>
      </tr>
      <tr>
        <td>Female, 25-34 years</td>
        <td>2021-02-08</td>
        <td>XBA2FwYbPZ1</td>
      </tr>
      <tr>
        <td>Unknown Sex, 5-14 years</td>
        <td>2020-06-22</td>
        <td>xevNodrE0jP</td>
      </tr>
      <tr>
        <td>5-14 years, Male</td>
        <td>2021-02-08</td>
        <td>YEgJBndPbIM</td>
      </tr>
      <tr>
        <td>Unknown Sex, 25-34 years</td>
        <td>2020-06-22</td>
        <td>yHfVe4aSFuF</td>
      </tr>
      <tr>
        <td>Male, 5-14 years</td>
        <td>2021-02-08</td>
        <td>yrPacW5BotF</td>
      </tr>
      <tr>
        <td>Female, 35-44 years</td>
        <td>2021-02-08</td>
        <td>ysu85dgwScU</td>
      </tr>
      <tr>
        <td>25-34 years, Female</td>
        <td>2021-02-08</td>
        <td>YSXeQGEdt0M</td>
      </tr>
      <tr>
        <td>Unknown Age, Female</td>
        <td>2020-06-22</td>
        <td>z7mHVm62pEJ</td>
      </tr>
      <tr>
        <td>Unknown Sex, Unknown Age</td>
        <td>2020-06-22</td>
        <td>ziqM3mo6sgD</td>
      </tr>
      <tr>
        <td>55-64 years, Male</td>
        <td>2021-02-08</td>
        <td>ZJFWAWtxBVA</td>
      </tr>
    </table>
    <h2 id="categoryOptionGroupSets">Category Option Group Sets</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Sex (Male/Female)</td>
        <td>2021-02-08</td>
        <td>CMrvZp5rmoC</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>2021-02-08</td>
        <td>dxmp3usPQIm</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>2021-02-08</td>
        <td>OZlTcjBnAsn</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>2021-02-08</td>
        <td>XxEFGdwxOJ0</td>
      </tr>
    </table>
    <h2 id="categoryOptionGroups">Category Option Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Shortname</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Female</td>
        <td>Female</td>
        <td>2021-02-08</td>
        <td>bqoVhX2RfG4</td>
      </tr>
      <tr>
        <td>25-34 years</td>
        <td>25-34 y</td>
        <td>2021-02-08</td>
        <td>cRskhJQLr4J</td>
      </tr>
      <tr>
        <td>65+ years</td>
        <td>65+ y</td>
        <td>2021-02-08</td>
        <td>DdhMoYLz6Un</td>
      </tr>
      <tr>
        <td>Male</td>
        <td>Male</td>
        <td>2021-02-08</td>
        <td>EVYKU2fIc6G</td>
      </tr>
      <tr>
        <td>15+ years (specific age)</td>
        <td>15+ years (specific)</td>
        <td>2021-02-08</td>
        <td>HkomAEMQt5e</td>
      </tr>
      <tr>
        <td>35-44 years</td>
        <td>35-44 y</td>
        <td>2021-02-08</td>
        <td>KkZHYvn7Zor</td>
      </tr>
      <tr>
        <td>15-24 years</td>
        <td>15-24 y</td>
        <td>2021-02-08</td>
        <td>L7gAblMOZKs</td>
      </tr>
      <tr>
        <td>55-64 years</td>
        <td>55-64 y</td>
        <td>2021-02-08</td>
        <td>QllZ8PveFCQ</td>
      </tr>
      <tr>
        <td>Unknown Sex</td>
        <td>Unk Sex</td>
        <td>2020-09-17</td>
        <td>SZJNeRyrh22</td>
      </tr>
      <tr>
        <td>5-14 years</td>
        <td>5-14 y</td>
        <td>2021-02-08</td>
        <td>V9t81g7Wspa</td>
      </tr>
      <tr>
        <td>0-14 years (specific age)</td>
        <td>0-14 years (specific)</td>
        <td>2021-02-08</td>
        <td>vckBfmugFI3</td>
      </tr>
      <tr>
        <td>45-54 years</td>
        <td>45-54 y</td>
        <td>2021-02-08</td>
        <td>y5yT8JF4uCA</td>
      </tr>
      <tr>
        <td>0-4 years</td>
        <td>0-4 y</td>
        <td>2021-02-08</td>
        <td>yuathFHLjNe</td>
      </tr>
      <tr>
        <td>Unknown age</td>
        <td>Unknown age</td>
        <td>2021-02-08</td>
        <td>YXE2HxNf3YB</td>
      </tr>
    </table>
    <h3>Category Option Group Sets - Category Option Groups</h3>
    <table>
      <tr>
        <th>Category Option Group Sets</th>
        <th>Category Option Groups</th>
      </tr>
      <tr>
        <td>Sex (Male/Female)</td>
        <td>Female</td>
      </tr>
      <tr>
        <td>Sex (Male/Female)</td>
        <td>Male</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>0-4 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>5-14 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>15-24 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>25-34 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>35-44 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>45-54 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>55-64 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>65+ years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>Unknown age</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>0-4 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>5-14 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>0-14 years (specific age)</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>15-24 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>25-34 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>35-44 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>45-54 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>55-64 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>65+ years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>15+ years (specific age)</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>Unknown age</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>Female</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>Male</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>Unknown Sex</td>
      </tr>
    </table>
    <h2 id="validationRules">Validation Rules</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Instruction</th>
        <th>Left side</th>
        <th>Operator</th>
        <th>Right side</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TB - DS-TB drugs distributed<=DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs distributed should be less than or equal to DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs distributed</td>
        <td>less_than_or_equal_to</td>
        <td>DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>2020-12-17</td>
        <td>A94nxQASTNJ</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-positive</td>
        <td>New pulmonary smear-positive (total) should equal New pulmonary smear-positive by age and sex</td>
        <td>New pulmonary smear-positive</td>
        <td>equal_to</td>
        <td>New pulmonary smear-positive by age and sex</td>
        <td>2021-06-17</td>
        <td>bDjCyRMtkHO</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock on hand<=DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs stock on hand should be less than or equal to DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs stock on hand</td>
        <td>less_than_or_equal_to</td>
        <td>DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>2020-12-17</td>
        <td>Bh6XT9sX0xt</td>
      </tr>
      <tr>
        <td>TB treatment outcome - HIV positive RR-/MDR-TB cases</td>
        <td>HIV positive RR-/MDR-TB cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>HIV positive RR-/MDR-TB cases registered</td>
        <td>equal_to</td>
        <td>HIV positive RR-/MDR-TB cases evaluated</td>
        <td>2021-02-08</td>
        <td>BrEM9udfDBs</td>
      </tr>
      <tr>
        <td>TB treatment outcome - HIV positive cases evaluated vs all cases evaluated</td>
        <td>Treatment outcomes evaluated for HIV+ cases should be less than or equal to number evaluated for all cases.</td>
        <td>HIV-positive TB cases, all types, evaluated</td>
        <td>less_than_or_equal_to</td>
        <td>TB cases, new and relapse, evaluated</td>
        <td>2021-02-08</td>
        <td>CdnLuYCeV8O</td>
      </tr>
      <tr>
        <td>TB/HIV treatment outcomes - new smear-negative or extrapulmonary cases</td>
        <td>TB/HIV new smear-negative or extrapulmonary cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>TB/HIV new pulmonary smear negative cases registered</td>
        <td>equal_to</td>
        <td>TB/HIV new pulmonary smear negative cases evaluated</td>
        <td>2021-02-08</td>
        <td>cirjJFwPIJP</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs distributed<=DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs distributed should be less than or equal to DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs distributed</td>
        <td>less_than_or_equal_to</td>
        <td>DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>2020-12-17</td>
        <td>DClPdUIzqUQ</td>
      </tr>
      <tr>
        <td>TB treatment outcome - re-treatment cases</td>
        <td>Re-treatment cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>Re-treatment cases registered</td>
        <td>equal_to</td>
        <td>Re-treatment cases evaluated</td>
        <td>2021-02-08</td>
        <td>dFPw66vAMqp</td>
      </tr>
      <tr>
        <td>TB treatment outcome - new pulmonary smear-positive</td>
        <td>New pulmonary smear-positive cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>Pulmonary smear-positive registered</td>
        <td>equal_to</td>
        <td>New pulmonary smear positive cases evaluated</td>
        <td>2021-02-08</td>
        <td>DgcbOHn3Sl9</td>
      </tr>
      <tr>
        <td>TB treatment outcome - HIV positive RR-TB/MDR-TB cases evaluated vs all RR-TB/MDR-TB cases evaluated</td>
        <td>Treatment outcomes evaluated for HIV+ RR-TB/MDR-TB cases should be less than or equal to number evaluated for all RR-TB/MDR-TB cases.</td>
        <td>HIV positive RR-TB/MDR-TB cases evaluated</td>
        <td>less_than_or_equal_to</td>
        <td>RR-/MDR-TB cases evaluated</td>
        <td>2021-02-08</td>
        <td>dmTcdHIs9MH</td>
      </tr>
      <tr>
        <td>HIV - HIV-positive TB patients on antoretroviral therapy (ART) (by time of outcome)</td>
        <td>HIV-positive TB patients on antiretroviral therapy (ART) should be less than or equal to the number of HIV+ TB cases.</td>
        <td>HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
        <td>less_than_or_equal_to</td>
        <td>TB patients notified with positive HIV test result recorded</td>
        <td>2021-06-17</td>
        <td>EG3H3WrJnKe</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs redistributed<=DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs redistributed should be less than or equal to DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs redistributed</td>
        <td>less_than_or_equal_to</td>
        <td>DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>2020-12-17</td>
        <td>gLOa8aVCPzl</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges redistributed<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges redistributed should be less than or equal to GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges redistributed</td>
        <td>less_than_or_equal_to</td>
        <td>GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>2020-12-17</td>
        <td>gYATvcNPKIt</td>
      </tr>
      <tr>
        <td>TB/HIV testing (by time of outcome)</td>
        <td></td>
        <td>TB patients HIV tested</td>
        <td>greater_than_or_equal_to</td>
        <td>TB patients HIV positive</td>
        <td>2021-02-08</td>
        <td>hXd2GANq20y</td>
      </tr>
      <tr>
        <td>TB - New extrapulmonary cases</td>
        <td>New extrapulmonary cases (total) should equal New extrapulmonary cases by age and sex</td>
        <td>New extrapulmonary cases</td>
        <td>equal_to</td>
        <td>New extrapulmonary cases by age and sex</td>
        <td>2021-06-17</td>
        <td>hZveAwRhLRh</td>
      </tr>
      <tr>
        <td>TB treatment outcome - bacteriologically confirmed new and relapse</td>
        <td>Bacteriologically confirmed cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>Bacteriologically confirmed new and relapse cases registered</td>
        <td>equal_to</td>
        <td>Bacteriologically confirmed new and relapse cases evaluated</td>
        <td>2021-02-08</td>
        <td>i2EH9txXMoA</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs redistributed<=DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs redistributed should be less than or equal to DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs redistributed</td>
        <td>less_than_or_equal_to</td>
        <td>DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>2020-12-17</td>
        <td>IKW3q4ca3xS</td>
      </tr>
      <tr>
        <td>TB treatment outcome - clinically diagnosed new and relapse cases</td>
        <td>Clinically diagnosed cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>Clinically diagnosed new and relapse cases registered</td>
        <td>equal_to</td>
        <td>Clinically diagnosed new and relapse cases evaluated</td>
        <td>2021-02-08</td>
        <td>IqZfVeLaS8o</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs discarded<=DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs discarded should be less than or equal to DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs discarded</td>
        <td>less_than_or_equal_to</td>
        <td>DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>2020-12-17</td>
        <td>IrV3psd73XS</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges stock on hand<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges stock on hand should be less than or equal to GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges stock on hand</td>
        <td>less_than_or_equal_to</td>
        <td>GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>2020-12-17</td>
        <td>KituK0VHFr5</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock on hand<=DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs stock on hand should be less than or equal to DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>DR-TB drugs stock on hand</td>
        <td>less_than_or_equal_to</td>
        <td>DR-TB drugs opening balance + DR-TB drugs received</td>
        <td>2021-03-20</td>
        <td>KsWRlQDgPvF</td>
      </tr>
      <tr>
        <td>TB/HIV treatment outcomes - new smear-positive cases</td>
        <td>TB/HIV new smear-positive cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>TB/HIV new pulmonary smear positive cases registered</td>
        <td>equal_to</td>
        <td>TB/HIV new pulmonary smear positive cases evaluated</td>
        <td>2021-02-08</td>
        <td>MUford0vbj6</td>
      </tr>
      <tr>
        <td>HIV - HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)</td>
        <td>HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) should be less than or equal to HIV+ TB cases</td>
        <td>HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
        <td>less_than_or_equal_to</td>
        <td>TB patients notified with positive HIV test result recorded</td>
        <td>2021-06-17</td>
        <td>MWDQUNd4sZE</td>
      </tr>
      <tr>
        <td>TB treatment outcome - RR-TB/MDR-TB cases</td>
        <td>RR-TB/MDR-TB cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>RR-/MDR-TB cases registered</td>
        <td>equal_to</td>
        <td>RR-/MDR-TB cases evaluated</td>
        <td>2021-02-08</td>
        <td>NraYwd1wryz</td>
      </tr>
      <tr>
        <td>TB treatment outcome - HIV positive cases in cohort vs all cases in cohort</td>
        <td>Cases in cohort for treatment outcomes for HIV+ cases should be less than or equal to number cases in cohort for all cases.</td>
        <td>HIV-positive TB cases, all types, in cohort</td>
        <td>less_than_or_equal_to</td>
        <td>TB cases, new and relapse, in cohort</td>
        <td>2021-02-08</td>
        <td>OzZNs2vflPV</td>
      </tr>
      <tr>
        <td>TB treatment outcome - previously treated (excluding relapse)</td>
        <td>Previously treated (excluding relapse) cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>Previously treated cases registered</td>
        <td>equal_to</td>
        <td>Previously treated cases evaluated</td>
        <td>2021-02-08</td>
        <td>PNTVBHv8tVQ</td>
      </tr>
      <tr>
        <td>HIV - HIV-positive TB patients on antiretroviral therapy (ART)</td>
        <td>HIV-positive TB patients on antiretroviral therapy (ART) should be less than or equal to the number of HIV+ TB cases.</td>
        <td>HIV-positive TB patients started/continued antiretroviral therapy (ART)</td>
        <td>less_than_or_equal_to</td>
        <td>TB patients notified with positive HIV test result recorded</td>
        <td>2021-06-17</td>
        <td>puOMC36U2ad</td>
      </tr>
      <tr>
        <td>TB - Laboratory-confirmed MDR-TB cases indentified</td>
        <td>Laboratory-confirmed RR/MDR-TB cases identified should be greater than or equal to laboratory-confirmed MDR-TB cases identified</td>
        <td>Laboratory-confirmed RR-TB or MDR-TB cases</td>
        <td>greater_than_or_equal_to</td>
        <td>Laboratory-confirmed MDR-TB cases</td>
        <td>2021-06-17</td>
        <td>QR2H0WwvqRc</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs discarded<=DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs discarded should be less than or equal to DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>DS-TB drugs discarded</td>
        <td>less_than_or_equal_to</td>
        <td>DS-TB drugs opening balance + DS-TB drugs received</td>
        <td>2020-12-17</td>
        <td>quA9Tst6XvA</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock out days<=30 days</td>
        <td>DS-TB drugs stock out days should be less than or equal to 30 days</td>
        <td> Stock out days</td>
        <td>less_than_or_equal_to</td>
        <td>30 days</td>
        <td>2021-03-20</td>
        <td>rmcUggjpX0w</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock out days <=30 days</td>
        <td>DR-TB drugs stock out days should be less than or equal to 30 days</td>
        <td> Stock out days</td>
        <td>less_than_or_equal_to</td>
        <td>30 days</td>
        <td>2021-03-20</td>
        <td>rnzCWOng6Yb</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges distributed<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges distributed should be less than or equal to GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges distributed</td>
        <td>less_than_or_equal_to</td>
        <td>GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>2020-12-17</td>
        <td>rxnZIOr6BRY</td>
      </tr>
      <tr>
        <td>TB treatment outcome - XDR-TB cases</td>
        <td>XDR-TB cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>XDR-TB cases registered</td>
        <td>equal_to</td>
        <td>XDR-TB cases evaluated</td>
        <td>2021-02-08</td>
        <td>sD50FRetx1n</td>
      </tr>
      <tr>
        <td>TB - New and relapse TB cases</td>
        <td>New and relapse cases by type should be the same as new a relapse cases by age and sex.</td>
        <td>New and relapse cases by type</td>
        <td>equal_to</td>
        <td>New and relapse cases by age and sex</td>
        <td>2021-06-17</td>
        <td>sms4F5mp9T1</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges discarded<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges discarded should be less than or equal to GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>GenExpert Cartridges discarded</td>
        <td>less_than_or_equal_to</td>
        <td>GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
        <td>2020-12-17</td>
        <td>SoAZiNlwjMc</td>
      </tr>
      <tr>
        <td>TB treatment outcome - HIV positive RR-TB/MDR-TB cases registered vs all RR-TB/MDR-TB cases registered</td>
        <td>Cases in cohort for treatment outcomes for HIV+ RR-TB/MDR-TB cases should be less than or equal to number of cases in cohort for all RR-TB/MDR-TB cases.</td>
        <td>HIV+ RR-/MDR-TB cases in cohort</td>
        <td>less_than_or_equal_to</td>
        <td>RR-/MDR-TB cases in cohort</td>
        <td>2021-02-08</td>
        <td>SuKIF7R3QL4</td>
      </tr>
      <tr>
        <td>TB/HIV testing</td>
        <td></td>
        <td>TB patients HIV tested</td>
        <td>greater_than_or_equal_to</td>
        <td>TB patients HIV positive</td>
        <td>2021-02-08</td>
        <td>TV3eW5zYLep</td>
      </tr>
      <tr>
        <td>TB treatment outcome - HIV positive cases, new and relapse</td>
        <td>HIV positive cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>HIV positive cases registered</td>
        <td>equal_to</td>
        <td>HIV positive cases evaluated</td>
        <td>2021-02-08</td>
        <td>urQTVqNmQ9J</td>
      </tr>
      <tr>
        <td>TB - New pulmonary smear-negative/smear-unknown/smear not done</td>
        <td>New pulmonary smear-negative and new pulmonary smear-unknown/smear not done should equal new pulmonary smear-negative/smear-unknown/smear not done by age and sex</td>
        <td>New pulmonary smear negative/unknown/not done</td>
        <td>equal_to</td>
        <td>New pulmonary smear negative/unknown/not done by age and sex</td>
        <td>2021-06-17</td>
        <td>VhVCSKuqraP</td>
      </tr>
      <tr>
        <td>TB - Bacteriological examinations (TB)</td>
        <td>Bacteriological examinations performed should be greater than or equal to positive bacteriological examinations.</td>
        <td>Bacteriological examinations</td>
        <td>greater_than_or_equal_to</td>
        <td>Positive bacteriological examinations</td>
        <td>2021-06-17</td>
        <td>XTixOtLw8i8</td>
      </tr>
      <tr>
        <td>TB/HIV treatment outcomes - re-treatment</td>
        <td>TB/HIV re-treatment cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>TB/HIV re-treatment cases registered</td>
        <td>equal_to</td>
        <td>TB/HIV re-treatment cases evaluated</td>
        <td>2021-02-08</td>
        <td>y1O13PB5q3v</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges stock out days<=30 days</td>
        <td>GenExpert Cartridges stock out days should be less than or equal to 30 days</td>
        <td>Stock out days</td>
        <td>less_than_or_equal_to</td>
        <td>30 days</td>
        <td>2021-03-20</td>
        <td>z8nmv6DgbSC</td>
      </tr>
      <tr>
        <td>HIV - HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) (by time of outcome) </td>
        <td>HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) should be less than or equal to HIV+ TB cases</td>
        <td>HIV-positive TB patients started/continued co-trimoxazole preventive therapy</td>
        <td>less_than_or_equal_to</td>
        <td>TB patients notified with positive HIV test result recorded</td>
        <td>2021-06-17</td>
        <td>zANh0v8Sbr1</td>
      </tr>
      <tr>
        <td>TB treatment outcome - new pulmonary smear-negative</td>
        <td>New pulmonary smear-negative cases registered in the cohort should equal cases evaluated for outcomes.</td>
        <td>New pulmonary smear negative and extrapulmonary cases registered</td>
        <td>equal_to</td>
        <td>New pulmonary smear negative and extrapulmonary cases evaluated</td>
        <td>2021-02-08</td>
        <td>Zgk1ZBjOPc1</td>
      </tr>
    </table>
    <h2 id="validationRuleGroups">Validation Rule Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes - second line</td>
        <td>2021-02-08</td>
        <td>dRcxM3sLcNn</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>2021-03-20</td>
        <td>eq208zh8pOc</td>
      </tr>
      <tr>
        <td>Pre 2013: Case registrations</td>
        <td>2021-02-08</td>
        <td>iRCrvkyr4uw</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>2021-02-08</td>
        <td>sgf2zdOiwny</td>
      </tr>
      <tr>
        <td>Standard: RR/MDR-TB</td>
        <td>2021-02-08</td>
        <td>TumuGy1lmGY</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>2021-02-08</td>
        <td>vtIZawvyEM7</td>
      </tr>
      <tr>
        <td>Standard: Case registration</td>
        <td>2021-02-08</td>
        <td>xnxqh8hX6Ag</td>
      </tr>
    </table>
    <h3>Validation Rule Groups - Validation Rules</h3>
    <table>
      <tr>
        <th>Validation Rule Group</th>
        <th>Validation Rule</th>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes - second line</td>
        <td>TB treatment outcome - HIV positive RR-TB/MDR-TB cases evaluated vs all RR-TB/MDR-TB cases evaluated</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes - second line</td>
        <td>TB treatment outcome - HIV positive RR-/MDR-TB cases</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes - second line</td>
        <td>TB treatment outcome - XDR-TB cases</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes - second line</td>
        <td>TB treatment outcome - HIV positive RR-TB/MDR-TB cases registered vs all RR-TB/MDR-TB cases registered</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes - second line</td>
        <td>TB treatment outcome - RR-TB/MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - GenExpert Cartridges stock on hand<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DR-TB drugs discarded<=DR-TB drugs opening balance + DR-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DR-TB drugs distributed<=DR-TB drugs opening balance + DR-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - GenExpert Cartridges distributed<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DR-TB drugs stock out days <=30 days</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DS-TB drugs redistributed<=DS-TB drugs opening balance + DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DS-TB drugs distributed<=DS-TB drugs opening balance + DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DS-TB drugs stock out days<=30 days</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DS-TB drugs discarded<=DS-TB drugs opening balance + DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - GenExpert Cartridges discarded<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DS-TB drugs stock on hand<=DS-TB drugs opening balance + DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - GenExpert Cartridges redistributed<=GenExpert Cartridges opening balance + GenExpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DR-TB drugs stock on hand<=DR-TB drugs opening balance + DR-TB drugs received</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - GenExpert Cartridges stock out days<=30 days</td>
      </tr>
      <tr>
        <td>TB Stock Report</td>
        <td>TB - DR-TB drugs redistributed<=DR-TB drugs opening balance + DR-TB drugs received</td>
      </tr>
      <tr>
        <td>Pre 2013: Case registrations</td>
        <td>TB - New extrapulmonary cases</td>
      </tr>
      <tr>
        <td>Pre 2013: Case registrations</td>
        <td>TB - New pulmonary smear-negative/smear-unknown/smear not done</td>
      </tr>
      <tr>
        <td>Pre 2013: Case registrations</td>
        <td>TB - New pulmonary smear-positive</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>TB/HIV treatment outcomes - new smear-positive cases</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>TB treatment outcome - new pulmonary smear-negative</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>TB treatment outcome - re-treatment cases</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>TB treatment outcome - new pulmonary smear-positive</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>TB/HIV treatment outcomes - re-treatment</td>
      </tr>
      <tr>
        <td>Pre-2013: TB treatment outcomes</td>
        <td>TB/HIV treatment outcomes - new smear-negative or extrapulmonary cases</td>
      </tr>
      <tr>
        <td>Standard: RR/MDR-TB</td>
        <td>TB - Laboratory-confirmed MDR-TB cases indentified</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>HIV - HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) (by time of outcome) </td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB/HIV testing (by time of outcome)</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>HIV - HIV-positive TB patients on antoretroviral therapy (ART) (by time of outcome)</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB treatment outcome - bacteriologically confirmed new and relapse</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB treatment outcome - previously treated (excluding relapse)</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB treatment outcome - clinically diagnosed new and relapse cases</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB treatment outcome - HIV positive cases, new and relapse</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB treatment outcome - HIV positive cases evaluated vs all cases evaluated</td>
      </tr>
      <tr>
        <td>Standard: TB treatment outcomes</td>
        <td>TB treatment outcome - HIV positive cases in cohort vs all cases in cohort</td>
      </tr>
      <tr>
        <td>Standard: Case registration</td>
        <td>TB - Bacteriological examinations (TB)</td>
      </tr>
      <tr>
        <td>Standard: Case registration</td>
        <td>TB/HIV testing</td>
      </tr>
      <tr>
        <td>Standard: Case registration</td>
        <td>HIV - HIV-positive TB patients on antiretroviral therapy (ART)</td>
      </tr>
      <tr>
        <td>Standard: Case registration</td>
        <td>HIV - HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)</td>
      </tr>
      <tr>
        <td>Standard: Case registration</td>
        <td>TB - New and relapse TB cases</td>
      </tr>
    </table>
    <h2 id="predictorGroups">Predictor Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
        <th>Predictors</th>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>2021-02-18</td>
        <td>xjHbKETc1xK</td>
        <td>TB - Facilities with DS-TB drugs stockout days reported; TB - Facilities with GenExpert cartridges stockout days reported; TB - Facilities without DR-TB drugs stockout days reported; TB - GenExpert Cartridges opening balance; TB - Facilities without GenExpert cartridges stockout days reported; TB - Facilities without DS-TB drugs stockout days reported; TB - DS-TB drugs opening balance; TB - Facilities with DR-TB drugs stockout days reported; TB - DR-TB drugs opening balance</td>
      </tr>
    </table>
    <h2 id="predictors">Predictors</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Generator</th>
        <th>Sequential samples</th>
        <th>Annual samples</th>
        <th>Target data element</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TB - DR-TB drugs opening balance</td>
        <td>DR-TB drugs stock on-hand</td>
        <td>1</td>
        <td>0</td>
        <td>TB - DR-TB drugs opening balance</td>
        <td>2020-12-17</td>
        <td>acbN2iRiVo9</td>
      </tr>
      <tr>
        <td>TB - Facilities with DS-TB drugs stockout days reported</td>
        <td>if(DS-TB drugs stock out days> 0,1,0)</td>
        <td>0</td>
        <td>0</td>
        <td>TB - Facilities with DS-TB drugs stockout days reported</td>
        <td>2021-03-19</td>
        <td>etVGXYgre3v</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges opening balance</td>
        <td>GenExpert Cartridges opening balance</td>
        <td>1</td>
        <td>0</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
        <td>2020-12-17</td>
        <td>IWZmf5J4pWA</td>
      </tr>
      <tr>
        <td>TB - Facilities with DR-TB drugs stockout days reported</td>
        <td>if(DR-TB drugs stock out days> 0,1,0)</td>
        <td>0</td>
        <td>0</td>
        <td>TB - Facilities with DR-TB drugs stockout days reported</td>
        <td>2021-03-19</td>
        <td>lMmTOYCrExY</td>
      </tr>
      <tr>
        <td>TB - Facilities with GenExpert cartridges stockout days reported</td>
        <td>if(GenExpert Cartridges stock out days> 0,1,0)</td>
        <td>0</td>
        <td>0</td>
        <td>TB - Facilities with GeneXpert cartridges stockout days reported</td>
        <td>2021-03-19</td>
        <td>SDs6uhUjwZ6</td>
      </tr>
      <tr>
        <td>TB - Facilities without GenExpert cartridges stockout days reported</td>
        <td>if(GenExpert Cartridges stock out days== 0,1,0)</td>
        <td>0</td>
        <td>0</td>
        <td>TB - Facilities without GeneXpert cartridges stockout days reported</td>
        <td>2021-02-18</td>
        <td>THRKEGZpwxw</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs opening balance</td>
        <td>DS-TB drugs stock on-hand</td>
        <td>1</td>
        <td>0</td>
        <td>TB - DS-TB drugs opening balance</td>
        <td>2020-12-17</td>
        <td>uss7ydeNXfY</td>
      </tr>
      <tr>
        <td>TB - Facilities without DS-TB drugs stockout days reported</td>
        <td>if(DS-TB drugs stock out days== 0,1,0)</td>
        <td>0</td>
        <td>0</td>
        <td>TB - Facilities without DS-TB drugs stockout days reported</td>
        <td>2021-03-20</td>
        <td>V8BmHyoxomf</td>
      </tr>
      <tr>
        <td>TB - Facilities without DR-TB drugs stockout days reported</td>
        <td>if(DR-TB drugs stock out days== 0,1,0)</td>
        <td>0</td>
        <td>0</td>
        <td>TB - Facilities without DR-TB drugs stockout days reported</td>
        <td>2021-02-18</td>
        <td>y422tw0arBN</td>
      </tr>
    </table>
    <h2 id="indicatorGroups">Indicator Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Shortname</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Population estimates</td>
        <td></td>
        <td>2021-02-08</td>
        <td>I13HBLJTJMb</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td></td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td></td>
        <td>2021-05-03</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QCrsjqhAcWA</td>
      </tr>
      <tr>
        <td>TB</td>
        <td></td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td></td>
        <td>2021-02-08</td>
        <td>V4SoC7TzFMi</td>
      </tr>
    </table>
    <h3>Indicator Groups - Indicators</h3>
    <table>
      <tr>
        <th>Indicator Group</th>
        <th>Indicator</th>
      </tr>
      <tr>
        <td>Population estimates</td>
        <td>GEN - Population total</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Cured (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for HIV or with known HIV status (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for HIV with positive test recorded (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cohort size (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (previously treated, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases recorded as HIV positive started on ART</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Died (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB treatment success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB treatment success rate (previously treated DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for HIV or with known HIV status</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Failed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, pulmonary smear positive) by age group and sex</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Lost to follow-up (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases recorded as HIV positive started on CPT</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB treatment success rate (all DS and DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for HIV or with known HIV status - all cases (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases tested for HIV with positive test recorded</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Not evaluated (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB treatment success rate (all DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) by age group and sex</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases recorded as HIV positive started on CPT (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new, extrapulmonary) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB notification rate (all cases, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Completed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB cases recorded as HIV positive started on ART (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Proportion of GeneXpert cartridges unusable</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs wastage rate (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs usable stock</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs closing balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs stock discrepancy (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs closing balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Health facilities with DR-TB drugs stock-out days (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs stock coverage time</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Proportion of DS-TB drugs consumed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Proportion of GeneXpert cartridges consumed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert cartridges stock discrepancy (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs usable stock</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert cartridges closing balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Proportion of DR-TB drugs unusable</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert usable stock</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs stock coverage time</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DR-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs stock discrepancy (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Proportion of DS-TB drugs unusable</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert cartridges stock coverage time</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - GeneXpert cartridges wastage rate (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs wastage rate (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Proportion of DR-TB drugs consumed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Health facilities with DS-TB drugs stock-out days (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - Health facilities with GeneXpert cartridges stock-out days (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>TB - DS-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new) (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB: Cured - new smear-positive (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Cured (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Lost to follow-up (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases recorded as HIV positive started on CPT at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV or with known HIV status (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Lost to follow-up (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Died (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV with positive test recorded (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cohort size (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (previously treated, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases recorded as HIV positive started on ART</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Died (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Completed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV or with known HIV status at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not evaluated (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment success rate (previously treated DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV or with known HIV status</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Cured (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment failed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Completed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Failed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not evaluated (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Failed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Failed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Cured (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Failed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, pulmonary smear positive) by age group and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Lost to follow-up (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases recorded as HIV positive started on CPT</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Completed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases recorded as HIV positive started on ART at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Died (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment success rate (all DS and DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV or with known HIV status - all cases (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Lost to follow-up (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV with positive test recorded</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not evaluated (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Died (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not evaluated (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment success rate (all DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for HIV with positive test recorded at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) by age group and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Cured (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Lost to follow-up (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases recorded as HIV positive started on CPT (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment completed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new, extrapulmonary) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Died (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB notification rate (all cases, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Not evaluated (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Completed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB cases recorded as HIV positive started on ART (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB: Cured - new smear-positive (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Cured (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Lost to follow-up (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases recorded as HIV positive started on CPT at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for HIV or with known HIV status (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Lost to follow-up (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Died (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for HIV with positive test recorded (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cohort size (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (previously treated, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases recorded as HIV positive started on ART</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Died (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Completed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for HIV or with known HIV status at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not evaluated (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment success rate (previously treated DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for HIV or with known HIV status</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Cured (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment failed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Completed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Failed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not evaluated (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Failed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Failed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Cured (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Failed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Lost to follow-up (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases recorded as HIV positive started on CPT</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Completed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases recorded as HIV positive started on ART at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Died (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment success rate (all DS and DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Lost to follow-up (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for HIV with positive test recorded</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not evaluated (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Died (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not evaluated (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment success rate (all DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases tested for HIV with positive test recorded at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Cured (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Lost to follow-up (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases recorded as HIV positive started on CPT (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment completed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new, extrapulmonary) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Died (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB notification rate (all cases, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Not evaluated (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Completed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB cases recorded as HIV positive started on ART (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
      </tr>
    </table>
    <h2 id="indicators">Indicators</h2>
    <table>
      <tr>
        <th>UID</th>
        <th>Name</th>
        <th>Shortname</th>
        <th>Code</th>
        <th>Description</th>
        <th>Numerator</th>
        <th>Denominator</th>
        <th>Type</th>
        <th>Last updated</th>
        <th>Indicator group UID</th>
      </tr>
      <tr>
        <td>AAiHWXynwMP</td>
        <td>TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Completed (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_CMPLT</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Completed (completed) - bacteriologically confirmed new and relapse</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>aArkaKMHNhw</td>
        <td>TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Not evaluated (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_NEVAL</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Not evaluated</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>AgJYWRktH9o</td>
        <td>TB - Proportion of GeneXpert cartridges unusable</td>
        <td>GeneXpert cartridges unusable (%)</td>
        <td>TB_CARTRIDGES_UNUSABLE</td>
        <td>Proportion of GeneXpert cartridges that, out of the opening balance, could not be used due to either redistribution or discard</td>
        <td>TB - GeneXpert Cartridges discarded + TB - GeneXpert Cartridges redistributed</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
        <td>Percentage</td>
        <td>2021-03-04</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ajJXlrOt4NU</td>
        <td>TB - TB: Cured - new smear-positive (%)</td>
        <td>Cured new smear+ (%)</td>
        <td>TB_C_PCNT_NEW_SP_CUR</td>
        <td>Number of new smear-positive TB patients who were cured as a percentage of the total cohort registered</td>
        <td>Cured</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>AK3YLZQERtT</td>
        <td>TB - DR-TB drugs wastage rate (%)</td>
        <td>DR-TB drugs wastage rate</td>
        <td>DR-TB_DRUGS_WASTAGE_RATE</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock used=([Closing balance]-[Stock at hand]) + discarded + dispensed to patient)</td>
        <td>Percentage</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>AmkNXobiXxa</td>
        <td>TB - Cured (all DS-TB cases) (%)</td>
        <td>Cured (all DS-TB) (%)</td>
        <td>TB_C_PCNT_CUR</td>
        <td>Number of new and previously treated TB patients who were cured as a percentage of the total cohort registered</td>
        <td>total cured</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>aPfDXoI0tPS</td>
        <td>TB - Notified TB cases (new, all forms) aged 0-14 (%)</td>
        <td>0-14 (%) </td>
        <td>TB_C_PCNT_NEW_014</td>
        <td></td>
        <td>Number of TB cases aged under 15</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>aPT4OksC5z7</td>
        <td>TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
        <td>0-14 year olds (new and relapse, all forms TB) (%)</td>
        <td>TB_C_PCNT_KIDS</td>
        <td></td>
        <td>Number of TB cases aged 0-15 (new and relapse only)</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>AwZgWwQaHvR</td>
        <td>TB - DR-TB drugs opening balance</td>
        <td>DR-TB drugs opening balance</td>
        <td>TB_DRDRUGS_OPENING_BALANCE</td>
        <td>Number of DR-TB drugs opening balance</td>
        <td>TB - DR-TB drugs opening balance</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>axHsIHLBpRm</td>
        <td>TB - Lost to follow-up (new smear-positive TB cases) (%)</td>
        <td>Lost (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_LOST</td>
        <td>Number of new smear-positive TB patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Lost</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>B0Wm5ZKo9AY</td>
        <td>TB - TB cases recorded as HIV positive started on CPT at outcome</td>
        <td>TB/HIV on CPT at outcome</td>
        <td>TB_C_HIV_CPT_OUT</td>
        <td>New and relapse HIV-positive TB cases started/continued co-trimoxazole preventive therapy (CPT) recorded at the time of treatment outcome (all TB cases for pre-2013 definitions).</td>
        <td>HIV on CPT at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>B1HKzq73wJr</td>
        <td>TB - Notified TB cases (new, all forms) aged 15-24 (%)</td>
        <td>15-24 (%)</td>
        <td>TB_C_PCNT_NEW_1524</td>
        <td></td>
        <td>Number of TB cases aged 15-24</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>bCrpRBKKPhA</td>
        <td>TB - DS-TB drugs usable stock</td>
        <td>DS-TB drugs usable stock</td>
        <td>TB_DSDRUGS_USABLE_STOCK</td>
        <td></td>
        <td>opening balance+received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>bD1Z2FmbHKK</td>
        <td>TB - DS-TB drugs opening balance</td>
        <td>DS-TB drugs opening balance</td>
        <td>TB_DSDRUGS_OPENING_BALANCE</td>
        <td>Number of DS-TB drugs opening balance</td>
        <td>TB - DS-TB drugs opening balance</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>bK3hiVktvHR</td>
        <td>TB - DR-TB drugs discarded</td>
        <td>DR-TB drugs discarded</td>
        <td>TB_DRDRUGS_DISCARDED</td>
        <td>Number of DR-TB drugs discarded during the reporting period (expired, damaged, etc.)</td>
        <td>DR-TB drugs discarded</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>BmxOvSZmatv</td>
        <td>TB - DR-TB drugs received</td>
        <td>DR-TB drugs received</td>
        <td>TB_DRDRUGS_RECV</td>
        <td>Number of DR-TB drugs received</td>
        <td>TB - DR-TB drugs received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>BzFJFOFMVCu</td>
        <td>TB - GeneXpert Cartridges stock out days</td>
        <td>GeneXpert Cartridges stock out days</td>
        <td>TB_CARTRIDGE_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of GeneXpert Cartridges (at any point during the day) during the reporting period.</td>
        <td>GenExpert Cartridges stock out days</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>C4cDwij2oqU</td>
        <td>TB - TB cases tested for HIV or with known HIV status (%)</td>
        <td>TB/HIV tested (%)</td>
        <td>TB_C_PCNT_HIVTEST</td>
        <td>New and relapse TB cases tested or with known HIV status as percentage of notified new and relapse TB cases (all TB cases tested of all TB cases notified for pre-2013)</td>
        <td>TB patients with known HIV status</td>
        <td>New and relapse TB cases notified and all TB cases notified (pre 2013)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>c5yG2hQbSWF</td>
        <td>TB - Lost to follow-up (previously treated DS-TB cases) (%)</td>
        <td>Lost (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_LOST_RET</td>
        <td>Number of previously treated/re-treated TB patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Total lost to follow-up previously treated TB patients</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>c6ju86FLKzU</td>
        <td>TB - Died (all DR-TB cases) (%)</td>
        <td>Died (all DR-TB) (%)</td>
        <td>TB_C_PCNT_DIED_2ND</td>
        <td>Number of TB patients who died as a percentage of the total cohort registered for 2nd line treatment </td>
        <td>Total died for 2nd line treatment</td>
        <td>Total cohort size of TB patients registered for 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>cbAQwCbhhoe</td>
        <td>TB - GeneXpert Cartridges issued</td>
        <td>GeneXpert cartridges issued</td>
        <td>TB_CARTRIDGE_ISSUED</td>
        <td>Number of GeneXpert cartridges issued</td>
        <td>TB - GenExpert Cartridges issued</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-06-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>cT1tyz6k18X</td>
        <td>TB - Notified TB cases (new, all forms) aged 35-44 (%)</td>
        <td>35-44 (%)</td>
        <td>TB_C_PCNT_NEW_3544</td>
        <td></td>
        <td>Number of TB cases aged 35-44</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>cX7gRvEV6kK</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (%)</td>
        <td>Tested for RR-TB (%)</td>
        <td>TB_C_PCNT_DST</td>
        <td>All TB cases tested for susceptibility to rifampicin (RR-TB) as a percentage of all TB cases notified</td>
        <td>Total number of cases tested for susceptibility to rifampicin</td>
        <td>Total notified</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>DdIWhMWSI8i</td>
        <td>TB - TB cases tested for HIV with positive test recorded (%)</td>
        <td>TB/HIV positive (%)</td>
        <td>TB_C_PCNT_HIVPOS</td>
        <td>New and relapse TB cases with positive HIV test result recorded as percentage of those tested or with known HIV status</td>
        <td>Known HIV-positive TB cases</td>
        <td>TB cases with known HIV status</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>DKdvXuIfxwl</td>
        <td>TB - DS-TB drugs closing balance</td>
        <td>DS-TB drugs closing balance</td>
        <td>TB_DSDRUGS_CLOSING_BAL</td>
        <td>Number of DS-TB drugs as closing balance [Opening balance + Received - Issued - Redistributed - Discarded] at the end of the reporting period</td>
        <td>DS-TB drugs closing bal</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>dlUf7CDF3l8</td>
        <td>TB - DR-TB drugs stock discrepancy (%)</td>
        <td>DR-TB drugs stock discrepancy (%)</td>
        <td>TB_DRDRUGS_DISCREPANCY</td>
        <td>Percentage of the item's stock discrepancy [Stock on hand - Closing balance] / Stock on hand</td>
        <td>DR-TB drugs stock discrepancy</td>
        <td>stock on hand</td>
        <td>Percentage</td>
        <td>2021-05-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>DV5YjkDeN36</td>
        <td>TB - TB cohort size (all cases, all forms)</td>
        <td>Cohort size (all DS-TB)</td>
        <td>TB_C_COH</td>
        <td>Number of new and previously treated TB patients registered, excluding cases moved to second-line treatment</td>
        <td>Total cohort size (all TB cases)</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>e92Z61nHBJY</td>
        <td>TB - DR-TB drugs stock out days</td>
        <td>DR-TB drugs stock out days</td>
        <td>TB_DRDRUGS_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of DR-TB drugs (at any point during the day) during the reporting period.</td>
        <td>DR-TB drugs stock out days</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>EHDTSPxpLco</td>
        <td>TB - DR-TB drugs closing balance</td>
        <td>DR-TB drugs closing balance</td>
        <td>TB_DRDRUGS_CLOSING_BAL</td>
        <td>Number of DR-TB drugs as closing balance [Opening balance + Received - Issued - Redistributed - Discarded] at the end of the reporting period</td>
        <td>DR-TB drugs closing bal</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>eIG3AwbOY4k</td>
        <td>TB - Notified TB cases (new, all forms) aged 65+ (%)</td>
        <td>65+ (%)</td>
        <td>TB_C_PCNT_NEW_65</td>
        <td></td>
        <td>Number of TB cases aged 65+</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>ePih3BMGzXU</td>
        <td>TB - Notified TB cases (previously treated, all forms)</td>
        <td>Previously treated (all forms TB)</td>
        <td>TB_C_RET_NREL</td>
        <td>Total number of TB cases re-registered for a new course of treatment (mainly treatment after failure and treatment after loss to follow-up patients) excluding relapse cases</td>
        <td>Total of all previously treated TB cases, but not relapse cases</td>
        <td></td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ERUV57qB52t</td>
        <td>TB - TB cases recorded as HIV positive started on ART</td>
        <td>TB/HIV on ART</td>
        <td>TB_C_HIV_ART</td>
        <td>New and relapse HIV-positive TB cases started/continued antiretroviral therapy (ART) (all TB cases for pre-2013 definitions)</td>
        <td>HIV on ART</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>eSTkclrbTy5</td>
        <td>TB - Health facilities with DR-TB drugs stock-out days (%)</td>
        <td>HF with DR-TB drugs stockout days (%)</td>
        <td>HF_WITH_DR-TB_DRUGS_STOCKOUT_DAYS_%</td>
        <td>Proportion of health facilities with DR-TB drugs stockout days</td>
        <td>HF with DR-TB drugs stockout days reported</td>
        <td>HF reporting stockout days</td>
        <td>Percentage</td>
        <td>2021-06-10</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ExXsF5qlzdc</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
        <td>15-24 (%) </td>
        <td>TB_C_PCNT_1524</td>
        <td></td>
        <td>Number of TB cases aged 15-24 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>F9eE09Dtqft</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
        <td>Lab-confirmed RR/MDR-TB</td>
        <td>TB_C_CONF_RRMDR</td>
        <td>Number of laboratory-confirmed RR-TB or MDR-TB cases identified among all TB patients (pulmonary or extrapulmonary, new, previously treated, or unknown treatment history) using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF, line probe assay), before or after starting treatment</td>
        <td>Number of lab-confirmed RR-TB or MDR-TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>fBAKfSVeUX2</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
        <td>Lab-confirmed RR/MDR-TB started MDR treatment (%)</td>
        <td>TB_C_PCNT_CONF_RRMDR_TX</td>
        <td>Percentage of laboratory confirmed rifampicin-resistant (RR-/MDR) TB cases notified and started on a second line MDR-TB treatment regimen among all cases with confirmed RR-/MDR-TB</td>
        <td>Lab-confirmed patients started treatment for MDR-TB</td>
        <td>Lab-confirmed RR-TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>fBwmklJ0VNp</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
        <td>0-4 (%) </td>
        <td>TB_C_PCNT_04</td>
        <td>Percentage of TB cases aged 0-4 among notified TB cases in given year (new and relapse, all forms)</td>
        <td>Number of TB cases aged 0-4 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>fdt3FPCzgDc</td>
        <td>TB - DR-TB drugs stock coverage time</td>
        <td>DR-TB drugs stock coverage time</td>
        <td>TB_DRTB_DRUGS_COVERAGE_TIME</td>
        <td></td>
        <td>usable stock</td>
        <td>consumed stock</td>
        <td>Rate (factor=1)</td>
        <td>2021-05-03</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>FETY3REnbWa</td>
        <td>TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
        <td>Previously treated (all forms TB) (%)</td>
        <td>TB_C_PCNT_RET</td>
        <td>Number of previously treated TB cases (previously treated including relapse, all forms) notified in given period as a percentage of the total notified TB cases.</td>
        <td>Total notified previously treated cases (INCLUDING relapse!)</td>
        <td>Total notified TB cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>FnadQQyc1dP</td>
        <td>TB - GeneXpert Cartridges redistributed</td>
        <td>GeneXpert Cartridges redistributed</td>
        <td>TB_CARTRIDGE_REDISTRIBUTED</td>
        <td>Number of GeneXpert Cartridges redistributed</td>
        <td>TB - GenExpert Cartridges redistributed</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>Fyx8nuRcxja</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new) (%)</td>
        <td>Tested for RR-TB (new) (%)</td>
        <td>TB_C_PCNT_DST_NEW</td>
        <td>New TB cases tested for susceptibility to rifampicin (RR-TB) as a percentage of all new TB cases notified</td>
        <td>Number of new TB cases tested for susceptibility to rifampicin</td>
        <td>All new TB cases notified (excluding the cases with unknown treatment history)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>QCrsjqhAcWA, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>g6tK0H6KkYe</td>
        <td>TB - Died (all DS-TB cases) (%)</td>
        <td>Died (all DS-TB) (%)</td>
        <td>TB_C_PCNT_DIED</td>
        <td>Number of new and previously treated TB patients who died as a percentage of the total cohort registered</td>
        <td>Total died</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>GbqUYVq0NLo</td>
        <td>TB - Proportion of DS-TB drugs consumed</td>
        <td>DS-TB drugs consumed (%)</td>
        <td>TB_DSTB_DRUGS_CONSUMED</td>
        <td>Proportion of DS-TB drugs that have been used over the opening balance of the same drugs</td>
        <td>TB - DS-TB drugs distributed</td>
        <td>TB - DS-TB drugs opening balance + received = usable stock</td>
        <td>Percentage</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>gcMtkbbotUv</td>
        <td>TB - GeneXpert Cartridges received</td>
        <td>GeneXpert Cartridges received</td>
        <td>TB_CARTRIDGE_RECV</td>
        <td>Number of GeneXpert Cartridges received</td>
        <td>TB - GenExpert Cartridges received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>gHZcDFFvq5x</td>
        <td>TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Died (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_DIED</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who died as a percentage of the total cohort registered</td>
        <td>Died</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>GjDECoLvM1z</td>
        <td>TB - Notified TB cases (new, all forms) aged 5-14 (%)</td>
        <td>5-14 (%)</td>
        <td>TB_C_PCNT_NEW_514</td>
        <td></td>
        <td>Number of TB cases aged 5-14</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>gm3SU0QX9tO</td>
        <td>TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
        <td>Ratio male:female (new and relapse, all forms TB)</td>
        <td>TB_C_RATIO_M_F</td>
        <td>Number of male TB cases (new and relapse, all forms) notified in given period compared to the female TB cases (new and relapse, all forms) notified in the same period. </td>
        <td>Total number of males</td>
        <td>Total number of females</td>
        <td>Rate (factor=1)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>gN08xtpAR9V</td>
        <td>TB - TB treatment success rate (all DS-TB) (%)</td>
        <td>Tx success (all DS-TB) (%)</td>
        <td>TB_C_ALLDS_TSR</td>
        <td>Number of all DS-TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of all DS-TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of all DS-TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>gPJEsVY8R39</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
        <td>New and relapse (pulm bac conf TB)</td>
        <td>TB_C_NEWINC_LABCONF</td>
        <td>Number of TB cases notified in a given year (new and relapse and history unknown; pulmonary bacteriologically confirmed)</td>
        <td>Pulm bact confirmed new and relapse and history unknown</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>h7bxqdKWYCa</td>
        <td>GEN - Population total</td>
        <td>Population</td>
        <td>GEN_E_POP_TOT</td>
        <td>Estimated total population</td>
        <td>total population</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>I13HBLJTJMb</td>
      </tr>
      <tr>
        <td>HBB4o9xQScX</td>
        <td>TB - Completed (previously treated DS-TB cases) (%)</td>
        <td>Completed (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_CMPLT_RET</td>
        <td>Number of previously treated/re-treated TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Total previously treated TB patients with completed treatment</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>HBkfpoEMWna</td>
        <td>TB - Notified TB cases (new, all forms) aged 55-64 (%)</td>
        <td>55-64 (%)</td>
        <td>TB_C_PCNT_NEW_5564</td>
        <td></td>
        <td>Number of TB cases aged 55-64</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>hO7plbvXQPQ</td>
        <td>TB - TB cases tested for HIV or with known HIV status at outcome</td>
        <td>TB/HIV tested at outcome</td>
        <td>TB_C_HIV_TEST_OUT</td>
        <td>New and relapse TB cases tested or with known HIV status at the time of treatment outcome (all TB cases for pre-2013 definitions) </td>
        <td>TB patients tested (new and relapse or all for pre-2013 definitions) recorded at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>HSLNfDLCbUc</td>
        <td>TB - Not evaluated (all DS-TB/HIV cases) (%)</td>
        <td>Not evaluated (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_NEVAL_HIV</td>
        <td>Number of new and previously treated TB/HIV patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Total not evaluated HIV TB</td>
        <td>Total cohort size (cases registered) HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>hSpmpUl6eJk</td>
        <td>TB - DS-TB drugs received</td>
        <td>DS-TB drugs received</td>
        <td>TB_DSDRUGS_RECV</td>
        <td>Number of DS-TB drugs received</td>
        <td>TB - DS-TB drugs received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>IIbDJrLi4z5</td>
        <td>TB - TB treatment success rate (previously treated DS-TB) (%)</td>
        <td>Tx success (previously treated DS-TB) (%)</td>
        <td>TB_C_RET_TSR</td>
        <td>Number of previously treated (excluding relapse) TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of previously treated (excluding relapse) TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of previously treated (excluding relapse) TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of previously treated (excluding relapse) TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>j6wYomVhfNs</td>
        <td>TB - Laboratory-confirmed MDR-TB cases</td>
        <td>Lab-confirmed MDR-TB</td>
        <td>TB_C_CONF_MDR</td>
        <td>Number of laboratory-confirmed MDR-TB cases identified among all TB patients (pulmonary or extrapulmonary, new, previously treated, or unknown treatment history) using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF, line probe assay), before or after starting treatment</td>
        <td>Lab-confirmed MDR-TB</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>J7ChdEuwMPW</td>
        <td>TB - TB cases tested for HIV or with known HIV status</td>
        <td>TB/HIV tested</td>
        <td>TB_C_HIV_TEST</td>
        <td>New and relapse TB cases tested or with known HIV status (all TB cases for pre-2013 definitions)</td>
        <td>TB patients tested (new and relapse or all for pre-2013 definitions) </td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>JaXPqKA823j</td>
        <td>TB - Proportion of GeneXpert cartridges consumed</td>
        <td>GeneXpert cartridges consumed (%)</td>
        <td>TB_CARTRIDGES_CONSUMED</td>
        <td>Proportion of GeneXpert cartridges that have been used for diagnostics over the opening balace of GeneXpert cartridges</td>
        <td>TB - GenExpert Cartridges distributed</td>
        <td>TB - GenExpert Cartridges opening balance + received = usable stock</td>
        <td>Percentage</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>JCs9GgdcC7d</td>
        <td>TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
        <td>New and relapse (pulm clin diag TB)</td>
        <td>TB_C_NEWINC_CLINDX</td>
        <td>Number of TB cases notified in a given year (new and relapse and history unknown; pulmonary clinically diagnosed)</td>
        <td>Pulmonary clinically diagnosed new and relapse and history unknown</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>jDitMFtRib4</td>
        <td>TB - DS-TB drugs issued</td>
        <td>DS-TB drugs issued</td>
        <td>TB_DSDRUGS_ISSUED</td>
        <td>Number of DS-TB drugs issued</td>
        <td>TB - DS-TB drugs issued</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-06-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>JfrM1j1pYhc</td>
        <td>TB - Cured (all DR-TB cases) (%)</td>
        <td>Cured (all DR-TB) (%)</td>
        <td>TB_C_PCNT_CUR_2ND</td>
        <td>Number TB patients who were cured at the second line treatment as a percentage of the total cohort registered for the second line treatment</td>
        <td>Total cured TB patients of the second line treatment</td>
        <td>Total cohort size of TB patients from 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>jlzNtLhlpue</td>
        <td>TB - TB treatment failed (new smear-positive TB cases) (%)</td>
        <td>Failed (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_FAIL</td>
        <td>Number of new smear-positive TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Failed</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>jU1JpPt2T62</td>
        <td>TB - Notified TB cases (new, all forms) aged 0-4 (%)</td>
        <td>0-4 (%)</td>
        <td>TB_C_PCNT_NEW_04</td>
        <td></td>
        <td>Number of TB cases aged under 5</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>K8jFJ0e67kU</td>
        <td>TB - GeneXpert Cartridges discarded</td>
        <td>GeneXpert Cartridges discarded</td>
        <td>TB_CARTRIDGE_DISCARDED</td>
        <td>Number of GeneXpert Cartridges discarded during the reporting period (expired, damaged, etc.)</td>
        <td>GenExpert Cartridges discarded</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>KlETO0IOKtI</td>
        <td>TB - Notified TB cases (new, all forms) aged 25-34 (%)</td>
        <td>25-34 (%)</td>
        <td>TB_C_PCNT_NEW_2534</td>
        <td></td>
        <td>Number of TB cases aged 25-34</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>KQf9KBm7VW5</td>
        <td>TB - GeneXpert cartridges stock discrepancy (%)</td>
        <td>GeneXpert cartridges stock discrepancy (%)</td>
        <td>TB_CARTRIDGE_DISCREPANCY</td>
        <td>Percentage of the item's stock discrepancy [Stock on hand - Closing balance] / Stock on hand</td>
        <td>GenExpert cartridges stock discrepancy</td>
        <td>stock on hand</td>
        <td>Percentage</td>
        <td>2021-05-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>kWuyYvtjl6s</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
        <td>Tested for RR-TB (history unknown)</td>
        <td>TB_C_OTH_RTEST</td>
        <td>History unknown TB cases tested for susceptibility to rifampicin</td>
        <td>R testing for history unknown TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>L6TXyCTI2mW</td>
        <td>TB - Completed (all DR-TB cases) (%)</td>
        <td>Completed (all DR-TB) (%)</td>
        <td>TB_C_PCNT_CMPLT_2ND</td>
        <td>Number of TB patients who completed the 2nd line treatment as a percentage of the total cohort registered for 2nd line treatment</td>
        <td>TB patients with completed 2n line treatment</td>
        <td>Total cohort size of TB patients on 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>LmHsc7UGtQf</td>
        <td>TB - DR-TB drugs usable stock</td>
        <td>DR-TB drugs usable stock</td>
        <td>TB_DRDRUGS_USABLE_STOCK</td>
        <td></td>
        <td>opening balance+received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>lRAKLRVIMgp</td>
        <td>TB - Notified TB cases (all cases, all forms)</td>
        <td>All cases (all forms TB)</td>
        <td>TB_C_NOTIFIED</td>
        <td>Number of TB cases notified in a given year (all cases, all forms)</td>
        <td>All notified cases</td>
        <td></td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>m0VAZ280hFd</td>
        <td>TB - Failed (all DS-TB/HIV cases) (%)</td>
        <td>Failed (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_FAIL_HIV</td>
        <td>Number of new and previously treated TB/HIV patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Total failed treatment HIV TB</td>
        <td>Total cohort size HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>m1qHAB0I74y</td>
        <td>TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
        <td>Rate - new and relapse (pulm bac conf TB)</td>
        <td>TB_C_NEWINC_LABCONF_100K</td>
        <td>Number of TB cases notified in a given year (new and relapse, pulmonary bacteriologically confirmed), per 100, 000 population</td>
        <td>Pulm bact confirmed new and relapse and history unknown</td>
        <td>population</td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>mDpLYl0sbQd</td>
        <td>TB - GeneXpert cartridges closing balance</td>
        <td>GeneXpert cartridges closing balance</td>
        <td>TB_CARTRIDGE_CLOSING_BAL</td>
        <td>Number of GeneXpert Cartridges as closing balance [Opening balance + Received - Issued - Redistributed - Discarded] at the end of the reporting period</td>
        <td>GenExpert cartridges closing bal</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>MlqHbdCyibN</td>
        <td>TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
        <td>Rate - new and relapse (all forms TB)</td>
        <td>TB_C_NEWINC_100K</td>
        <td>Number of TB cases notified in a given year (new and relapse, all forms), per 100, 000 population</td>
        <td>New, relapse and cases with unknown treatment</td>
        <td>population </td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>mPz2CV8PamC</td>
        <td>TB - TB cases tested for susceptibility to rifampicin</td>
        <td>Tested for RR-TB</td>
        <td>TB_C_DST</td>
        <td>Total number of TB cases tested for susceptibility to rifampicin - RR-TB</td>
        <td>Total number of cases tested for susceptibility to rifampicin</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>N7OZj7DONas</td>
        <td>TB - Not evaluated (previously treated DS-TB cases) (%)</td>
        <td>Not evaluated (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_NEVAL_RET</td>
        <td>Number of previously treated/re-treated TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Total previously treated TB patients not evaluated</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NbbSAGzGYrH</td>
        <td>TB - Failed (all DS-TB cases) (%)</td>
        <td>Failed (all DS-TB) (%)</td>
        <td>TB_C_PCNT_FAIL</td>
        <td>Number of new and previously treated TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Total failed treatment</td>
        <td>Total cohort size</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>nbSUx9d1e1M</td>
        <td>TB - Proportion of DR-TB drugs unusable</td>
        <td>DR-TB drugs unusable (%)</td>
        <td>TB_DSSTB_DRUGS_UNUSABLE</td>
        <td>Proportion of DR-TB drugs that, out of the opening balance, could not be used due to either redistribution or discard</td>
        <td>TB - DR-TB drugs discarded + TB - DR-TB drugs redistributed</td>
        <td>TB - DR-TB drugs opening balance</td>
        <td>Percentage</td>
        <td>2021-03-04</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>nhoEcbYl2hU</td>
        <td>TB - Failed (previously treated DS-TB cases) (%)</td>
        <td>Failed (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_FAIL_RET</td>
        <td>Number of previously treated/re-treated TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Total failed treatment previously treated TB patients</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NlKiCH8eRVc</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
        <td>Lab-confirmed RR/MDR-TB started MDR treatment</td>
        <td>TB_C_CONF_RRMDR_TX</td>
        <td>Number of patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB. Include pulmonary and extrapulmonary TB and also patients diagnosed before the reporting period but started on treatment during the reporting period.</td>
        <td>TB cases started on MDR treatment </td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NNwvy3Ym6vj</td>
        <td>TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Lost (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_LOST</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who were lost to follow-up as a percentage of the total cohort registered</td>
        <td>Lost to follow-up</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NqBeQEiXK14</td>
        <td>TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%)</td>
        <td>Previously treated incl rel (pulm bac conf TB) (%)</td>
        <td>TB_PCNT_BAC_RET</td>
        <td>Number of previously treated TB cases which were confirmed bacteriologoically in given period as a percentage of the total previously treated pulmonary bacteriologically confirmed TB cases. INCLUDING relapses!</td>
        <td>Previously treated TB cases bac conf including relapse</td>
        <td>Previously treated pulmonary TB cases (bact conf and clin diag, smer +, smear -)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>o7QoPpjWR9h</td>
        <td>TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population</td>
        <td>Rate - new and relapse (pulm clin diag TB)</td>
        <td>TB_C_NEWINC_CLINDX_100K</td>
        <td>Number of TB cases notified in a given year (new and relapse, pulmonary clinically diagnosed), per 100, 000 population</td>
        <td>Pulm clin diagnosed new and relapse and history unknown</td>
        <td>population</td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>odbgarQuUvh</td>
        <td>TB - DR-TB drugs stock on hand</td>
        <td>DR-TB drugs stock on hand</td>
        <td>TB_DRDRUGS_STOCK_ON_HAND</td>
        <td>Number of DR-TB drugs stock on hand</td>
        <td>TB - DR-TB drugs stock on hand</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>onTdlaF4eFF</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
        <td>Tx success (new and relapse DS-TB/HIV) (%)</td>
        <td>TB_C_TBHIV_TSR</td>
        <td>Number of new and relapse HIV-positive TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of HIV-positive new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of new and relapse HIV-positive TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of new and relapse HIV-positive TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>OuSWXCijKks</td>
        <td>TB - Cured (previously treated DS-TB cases) (%)</td>
        <td>Cured (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_CUR_RET</td>
        <td>Number of previously treated/re-treated TB patients who were cured as a percentage of the total cohort registered</td>
        <td>Total cured previously treated TB patients</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>OvZVFIRgrtG</td>
        <td>TB - GeneXpert Cartridges stock on hand</td>
        <td>GeneXpert Cartridges stock on hand</td>
        <td>TB_CARTRIDGE_STOCK_ON_HAND</td>
        <td>Number of GeneXpert Cartridges stock on hand</td>
        <td>TB - GenExpert Cartridges stock on hand</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ozucBtxJm2l</td>
        <td>TB - DS-TB drugs stock on hand</td>
        <td>DS-TB drugs stock on hand</td>
        <td>TB_DSDRUGS_STOCK_ON_HAND</td>
        <td>Number of DS-TB drugs stock on hand</td>
        <td>TB - DS-TB drugs stock on hand</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>p18w24U0caC</td>
        <td>TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
        <td>Lab-confirmed RR/MDR-TB (%)</td>
        <td>TB_C_PCNT_RRMDR</td>
        <td>Laboratory-confirmed RR-TB or MDR-TB cases as a percentage of TB cases with drug susceptibility test results recorded for at least rifampicin, during a specified time period, usually one year.</td>
        <td>Number with laboratory-confirmed RR-TB or MDR-TB</td>
        <td>Number tested for susceptibility to rifampicifn</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>P6wlyWUyJHp</td>
        <td>TB - Failed (all DR-TB cases) (%)</td>
        <td>Failed (all DR-TB) (%)</td>
        <td>TB_C_PCNT_FAIL_2ND</td>
        <td>Number of TB patients whose treatment failed as a percentage of the total cohort registered for 2nd line treatment</td>
        <td>TB patients who failed 2nd line treatment </td>
        <td>Total cohort size</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>pe3UIgLzj8p</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (new)</td>
        <td>Tested for RR-TB (new)</td>
        <td>TB_C_NEW_RTEST</td>
        <td>New TB cases tested for susceptibility to rifampicin</td>
        <td>R testing for new TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>PgU1N0PfAwN</td>
        <td>TB - Notified TB cases (new, pulmonary smear positive) by age group and sex</td>
        <td>New (pulm smear + TB) by age and sex</td>
        <td>TB_C_NEWSP_AGESEX</td>
        <td>Number of TB cases notified in a given year (new; pulmonary smear positive) disaggregated by age groups and sex</td>
        <td>New pulmonary smear-positive TB cases by age and sex</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>PJ5fX7RGHZt</td>
        <td>TB - Lost to follow-up (all DS-TB cases) (%)</td>
        <td>Lost (all DS-TB) (%)</td>
        <td>TB_C_PCNT_LOST</td>
        <td>Number of new and previously treated TB patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Total lost to follow-up</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>PjSomS4AXiD</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
        <td>Tested for RR-TB (previously treated)</td>
        <td>TB_C_RET_RTEST</td>
        <td>Previously treated TB cases tested for susceptibility to rifampicin</td>
        <td>R testing for previously treated TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>pRHeUC3sjcO</td>
        <td>TB - GeneXpert usable stock</td>
        <td>GeneXpert usable stock</td>
        <td>TB_GENEXPERT_USABLE_STOCK</td>
        <td></td>
        <td>opening balance+received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>pS9zsya8eUi</td>
        <td>TB - DR-TB drugs issued</td>
        <td>DR-TB drugs issued</td>
        <td>TB_DRDRUGS_ISSUED</td>
        <td>Number of DR-TB drugs issued</td>
        <td>TB - DR-TB drugs issued</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-06-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>qzl44PwyQCY</td>
        <td>TB - TB cases recorded as HIV positive started on CPT</td>
        <td>TB/HIV on CPT</td>
        <td>TB_C_HIV_CPT</td>
        <td>New and relapse HIV-positive TB patients started/continued co-trimoxazole preventive therapy (CPT) (all TB cases for pre-2013 definitions)</td>
        <td>HIV on CPT</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>RfRy5y9ANl2</td>
        <td>TB - DS-TB drugs discarded</td>
        <td>DS-TB drugs discarded</td>
        <td>TB_DSDRUGS_DISCARDED</td>
        <td>Number of DS-TB drugs discarded during the reporting period (expired, damaged, etc.)</td>
        <td>DS-TB drugs discarded</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>RgcWLiawMTQ</td>
        <td>TB - Completed (all DS-TB/HIV cases) (%)</td>
        <td>Completed (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_CMPLT_HIV</td>
        <td>Number of new and previously treated TB/HIV patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Total completed treatment HIV TB</td>
        <td>Total cohort size (cases registered) HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>Ri9wLtxwnJu</td>
        <td>TB - DS-TB drugs stock coverage time</td>
        <td>DS-TB drugs stock coverage time</td>
        <td>TB_DSTB_DRUGS_COVERAGE_TIME</td>
        <td></td>
        <td>usable stock</td>
        <td>consumed stock</td>
        <td>Rate (factor=1)</td>
        <td>2021-05-03</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>RIMCpjlrVPz</td>
        <td>TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%)</td>
        <td>New (pulm bac conf TB) (%)</td>
        <td>TB_C_PCNT_BAC_NEW</td>
        <td>Number of new TB cases which were confirmed bacteriologoically in given period as a percentage of the total new pulmonary bacteriologically confirmed TB cases.</td>
        <td>New pulm bacteriologically confirmed cases (for old forms smear +)</td>
        <td>New pulmonary TB cases (bact conf and clin diag, smer +, smear -)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>RJlAMDG3FZn</td>
        <td>TB - TB cases recorded as HIV positive started on ART at outcome</td>
        <td>TB/HIV on ART at outcome</td>
        <td>TB_C_HIV_ART_OUT</td>
        <td>New and relapse HIV-positive TB cases started/continued antiretroviral therapy at the time of treatment outcome (ART) (all for pre-2013 definitions recorded)</td>
        <td>HIV on ART at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>RlFZHghqtq7</td>
        <td>TB - Died (all DS-TB/HIV cases) (%)</td>
        <td>Died (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_DIED_HIV</td>
        <td>Number of new and previously treated TB/HIV patients who died as a percentage of the total cohort registered</td>
        <td>Total died HIV TB</td>
        <td>Total cohort size (cases registered) of HIV TB </td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>rv14EhkmZof</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
        <td>45-54 (%) </td>
        <td>TB_C_PCNT_4554</td>
        <td></td>
        <td>Number of TB cases aged 45-54 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>sk4N1FMqDwQ</td>
        <td>TB - DR-TB drugs redistributed</td>
        <td>DR-TB drugs redistributed</td>
        <td>TB_DRDRUGS_REDISTRIBUTED</td>
        <td>Number of DR-TB drugs redistributed</td>
        <td>TB - DR-TB drugs redistributed</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>skv1s6LGh0N</td>
        <td>TB - DS-TB drugs stock discrepancy (%)</td>
        <td>DS-TB drugs stock discrepancy (%)</td>
        <td>TB_DSDRUGS_DISCREPANCY</td>
        <td>Percentage of the item's stock discrepancy [Stock on hand - Closing balance] / Stock on hand</td>
        <td>DS-TB drugs stock discrepancy</td>
        <td>stock on hand</td>
        <td>Percentage</td>
        <td>2021-05-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>SPJLukKxHaj</td>
        <td>TB - TB treatment success rate (all DS and DR-TB) (%)</td>
        <td>Tx success (all DS+DR-TB) (%)</td>
        <td>TB_C_ALLDSDR_TSR</td>
        <td>Number of all DS+DR TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of all DS+DR TB cases registered.</td>
        <td>Number of all DS+DR TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number DS+DR-TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>sqVJYe4DGLs</td>
        <td>TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
        <td>Unconfirmed RR/MDR-TB started MDR-TB treatment</td>
        <td>TB_C_UNCONF_RRMDR_TX</td>
        <td>Number of patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB. Include pulmonary and extrapulmonary TB and also patients diagnosed before the reporting period but started on treatment during the reporting period.</td>
        <td>non conf started on MDR treatment </td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>SrgAuZUkqHh</td>
        <td>TB - TB cases tested for HIV or with known HIV status - all cases (%)</td>
        <td>TB/HIV tested - all cases (%)</td>
        <td>TB_C_PCNT_HIVTEST_ALL</td>
        <td>All TB cases tested or with known HIV status as percentage of all notified TB cases</td>
        <td>TB patients with known HIV status</td>
        <td>Total notified TB (pre-2013 definitions) or total TB (standard definitions)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>Tm4N8CLJM9I</td>
        <td>TB - Lost to follow-up (all DR-TB cases) (%)</td>
        <td>Lost (all DR-TB) (%)</td>
        <td>TB_C_PCNT_LOST_2ND</td>
        <td>Number of TB patients lost to follow-up as a percentage of the total cohort registered for 2nd line treatment</td>
        <td>Total lost to follow-up previously treated TB patients for 2nd line treatment</td>
        <td>Total cohort size of TB patients on 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>trwSfpxsWcb</td>
        <td>TB - Notified TB cases (new, all forms) aged 45-54 (%)</td>
        <td>45-54 (%)</td>
        <td>TB_C_PCNT_NEW_4554</td>
        <td></td>
        <td>Number of TB cases aged 45-54</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>tSmuPZGxDdu</td>
        <td>TB - TB cases tested for HIV with positive test recorded</td>
        <td>TB/HIV positive</td>
        <td>TB_C_HIV_POS</td>
        <td>New and relapse TB cases with positive HIV test result recorded (all TB cases for pre-2013 definitions) </td>
        <td>TB patients with positive HIV test</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>TV1Qm6X0ILb</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
        <td>55-64 (%) </td>
        <td>TB_C_PCNT_5564</td>
        <td></td>
        <td>Number of TB cases aged 55-64 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>tvB7kjQuQda</td>
        <td>TB - Not evaluated (all DS-TB cases) (%)</td>
        <td>Not evaluated (all DS-TB) (%)</td>
        <td>TB_C_PCNT_NEVAL</td>
        <td>Number of new and previously treated TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Total not evaluated</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>TVbAl90q4tl</td>
        <td>TB - Died (new smear-positive TB cases) (%)</td>
        <td>Died (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_DIED</td>
        <td>Number of new smear-positive TB patients who died as a percentage of the total cohort registered</td>
        <td>Died</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>U1c4P0YOBC5</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
        <td>GeneXpert Cartridges opening balance</td>
        <td>TB_CARTRIDGE_OPENING_BALANCE</td>
        <td>Number of GeneXpert Cartridges opening balance</td>
        <td>TB - GenExpert Cartridges opening balance</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>uIaLNEz7eFy</td>
        <td>TB - Not evaluated (new smear-positive TB cases) (%)</td>
        <td>Not evaluated (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_NEVAL</td>
        <td>Number of new smear-positive TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Not evaluated</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>UiSEm1IJmhb</td>
        <td>TB - Proportion of DS-TB drugs unusable</td>
        <td>DS-TB drugs unusable (%)</td>
        <td>TB_DRSTB_DRUGS_UNUSABLE</td>
        <td>Proportion of DS-TB drugs that, out of the opening balance, could not be used due to either redistribution or discard</td>
        <td>TB - DS-TB drugs discarded + TB - DS-TB drugs redistributed</td>
        <td>TB - DS-TB drugs opening balance</td>
        <td>Percentage</td>
        <td>2021-03-04</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>v7cZx5SUBXP</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
        <td>35-44 (%) </td>
        <td>TB_C_PCNT_3544</td>
        <td></td>
        <td>Number of TB cases aged 35-44 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>v9ygyBUS4Rh</td>
        <td>TB - TB treatment success rate (all DR-TB) (%)</td>
        <td>Tx success (all DR-TB) (%)</td>
        <td>TB_C_RRMDR_TSR</td>
        <td>Number of rifampicin-resistant (RR) or multidrug-resistant (MDR) TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of rifampicin-resistant or multidrug-resistant TB cases started on second-line treatment</td>
        <td>Number of rifampicin-resistant or multidrug-resistant TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of rifampicin-resistant or multidrug-resistant TB cases started on second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>Vb6NHYRWTyi</td>
        <td>TB - GeneXpert cartridges stock coverage time</td>
        <td>GeneXpert cartridges stock coverage time</td>
        <td>TB_XPERT_COVERAGE_TIME</td>
        <td></td>
        <td>usable stock</td>
        <td>consumed stock</td>
        <td>Rate (factor=1)</td>
        <td>2021-04-30</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>vc2AIHZvwbQ</td>
        <td>TB - TB cases tested for HIV with positive test recorded at outcome</td>
        <td>TB/HIV positive at outcome</td>
        <td>TB_C_HIV_POS_OUT</td>
        <td>New and relapse TB cases with positive HIV test at the time of treatment outcome (all TB casesfor pre-2013 definitions)</td>
        <td>TB patients with positive HIV test recorded at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>VcwgKNqXO9n</td>
        <td>TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
        <td>Ratio 0-4:5-14 (new and relapse, all forms TB)</td>
        <td>TB_C_RATIO_04_514</td>
        <td>Number of TB cases (new and relapse, all forms) aged 0-4 notified in given period compared to the TB cases (new and relapse, all forms) aged 5-14 notified in the same period. </td>
        <td>Number of TB cases aged 0-4 (new and relapse, all forms)</td>
        <td>Number of TB cases aged 5-14 (new and relapse, all forms)</td>
        <td>Rate (factor=1)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>VDfuDVALf0f</td>
        <td>TB - GeneXpert cartridges wastage rate (%)</td>
        <td>GeneXpert cartridges wastage rate</td>
        <td>GENEXPERT_CARTRIDGES_WASTAGE_RATE</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock used=([Closing balance]-[Stock at hand]) + discarded + dispensed to patient)</td>
        <td>Percentage</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>VLtzufVWnHc</td>
        <td>TB - Notified TB cases (new and relapse, all forms) by age group and sex</td>
        <td>New and relapse (all forms TB) by age and sex</td>
        <td>TB_NEWREL_AGESEX</td>
        <td>Number of TB cases notified in a given year (new and relapse and history unknown; all forms) disaggregated by age groups and sex</td>
        <td>New and relapse TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>VTNrh2DfO91</td>
        <td>TB - Cured (all DS-TB/HIV cases) (%)</td>
        <td>Cured (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_CUR_HIV</td>
        <td>Number of TB/HIV patients who were cured as a percentage of the total cohort registered</td>
        <td>total cured - HIV TB cases</td>
        <td>Total cohort size (cases registered) of HIV TB </td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>vwRyMhcuZDh</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
        <td>65+ (%)</td>
        <td>TB_C_PCNT_65+</td>
        <td></td>
        <td>Number of TB cases aged 65+ (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>w3CiHTdwV4j</td>
        <td>TB - Lost to follow-up (all DS-TB/HIV cases) (%)</td>
        <td>Lost (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_LOST_HIV</td>
        <td>Number of new and previously treated TB/HIV patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Total lost to follow-up HIV TB </td>
        <td>Total cohort size (cases registered) HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>W4IZTF82Bwx</td>
        <td>TB - DS-TB drugs wastage rate (%)</td>
        <td>DS-TB drugs wastage rate</td>
        <td>DS-TB_DRUGS_WASTAGE_RATE</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock used=([Closing balance]-[Stock at hand]) + discarded + dispensed to patient)</td>
        <td>Percentage</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>w7apwGjX5oC</td>
        <td>TB - TB cases recorded as HIV positive started on CPT (%)</td>
        <td>TB/HIV on CPT (%)</td>
        <td>TB_C_PCNT_HIVCPT</td>
        <td>New and relapse HIV-positive TB cases started/continued co-trimoxazol preventive therapy as percentage of those HIV positive (all TB cases for pre-2013 definitions)</td>
        <td>TB/HIV on CPT</td>
        <td>Known HIV-positive TB cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>WBuAm3uZWWs</td>
        <td>TB - Proportion of DR-TB drugs consumed</td>
        <td>DR-TB drugs consumed (%)</td>
        <td>TB_DRTB_DRUGS_CONSUMED</td>
        <td>Proportion of DR-TB drugs that have been used over the opening balance of the same drugs</td>
        <td>TB - DR-TB drugs distributed</td>
        <td>TB - DR-TB drugs opening balance + distributed = usable stock</td>
        <td>Percentage</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>WCE27g52nBt</td>
        <td>TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Cured (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_CUR</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who were cured as a percentage of the total cohort registered</td>
        <td>Cured</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>WgDUfvpjXFq</td>
        <td>TB - TB treatment completed (new smear-positive TB cases) (%)</td>
        <td>Completed (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_CMPLT</td>
        <td>Number of new smear-positive TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Completed</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>whkj4kr4ghD</td>
        <td>TB - TB cases tested for susceptibility to rifampicin (previously treated) (%)</td>
        <td>Tested for RR-TB (previously treated)(%)</td>
        <td>TB_C_PCNT_DST_RET</td>
        <td>Previously treated TB cases (including relapses) tested for susceptibility to rifampicin (RR-TB) as a percentage of all previously treated (including relapses) TB cases notified</td>
        <td>Number of previously treated (incl. relapses) cases tested for susceptibility to rifampicin</td>
        <td>All previously treated (including relapses) TB cases notified</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>QCrsjqhAcWA, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>WID08ddfy5T</td>
        <td>TB - Health facilities with DS-TB drugs stock-out days (%)</td>
        <td>HF with DS-TB drugs stockout days (%)</td>
        <td>HF_WITH_DS-TB_DRUGS_STOCKOUT_DAYS_%</td>
        <td>Proportion of health facilities with DS-TB drugs stockout days</td>
        <td>HF with DS-TB drugs stockout days reported</td>
        <td>HF reporting stockout days</td>
        <td>Percentage</td>
        <td>2021-06-10</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>WRDnlKY9y1d</td>
        <td>TB - Notified TB cases (new, extrapulmonary) (%)</td>
        <td>New extrapulmonary TB (%)</td>
        <td>TB_C_PCNT_EP</td>
        <td>Number of extrapulmonary TB cases (new, bacteriologically confirmed and clinically diagnosed) notified in given period as a percentage of the total notified TB cases.</td>
        <td>New extrapulmonary cases</td>
        <td>Total new cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>wTmoLwBYFa8</td>
        <td>TB - Died (previously treated DS-TB cases) (%)</td>
        <td>Died (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_DIED_RET</td>
        <td>Number of previously treated/re-treated TB patients who died as a percentage of the total cohort registered</td>
        <td>Total died</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>WWephINt8ga</td>
        <td>TB - TB notification rate (all cases, all forms) per 100 000 population</td>
        <td>Rate - all cases (all forms TB)</td>
        <td>TB_C_NOTIFIED_100K</td>
        <td>Number of TB cases notified (all cases, all forms) in a given year, per 100, 000 population</td>
        <td>All notified cases</td>
        <td>population</td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>XjyUl0Jmjbj</td>
        <td>TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases)</td>
        <td>Failed (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_FAIL</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Failed</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>xlmDFjsyuiS</td>
        <td>TB - Not evaluated (all DR-TB cases) (%)</td>
        <td>Not evaluated (all DR-TB) (%)</td>
        <td>TB_C_PCNT_NEVAL_2ND</td>
        <td>Number of TB patients whose treatment outcome is unknown as a percentage of the total cohort registered on the 2nd line treatment </td>
        <td>Total TB patients not evaluated from 2nd line treatment</td>
        <td>Total cohort size of TB patients of 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>yGDEeabaiza</td>
        <td>TB - Completed (all DS-TB cases) (%)</td>
        <td>Completed (all DS-TB) (%)</td>
        <td>TB_C_PCNT_CMPLT</td>
        <td>Number of new and previously treated TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Total completed treatment</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>YWTs6xdTRFF</td>
        <td>TB - Notified TB cases (new and relapse, all forms)</td>
        <td>New and relapse (all forms TB)</td>
        <td>TB_C_NEWINC</td>
        <td>New episodes of TB, all forms, includes new cases, relapses and cases with unknown treatment history</td>
        <td>New, relapse and cases with unknown treatment history</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ZAkEhIOXlhS</td>
        <td>TB - TB cases recorded as HIV positive started on ART (%)</td>
        <td>TB/HIV on ART (%)</td>
        <td>TB_C_PCNT_HIVART</td>
        <td>New and relapse HIV-positive TB cases started/continued antiretroviral therapy (ART) as percentage of those HIV positive (all TB cases for pre-2013 definitions)</td>
        <td>TB/HIV on ART</td>
        <td>Known HIV-positive TB cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>zbgm5GueWu9</td>
        <td>TB - DS-TB drugs stock out days</td>
        <td>DS-TB drugs stock out days</td>
        <td>TB_DSDRUGS_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of DS-TB drugs (at any point during the day) during the reporting period.</td>
        <td>DS-TB drugs stock out days</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ZEGEI9XgtZU</td>
        <td>TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
        <td>Tx success (new and relapse DS-TB) (%)</td>
        <td>TB_C_NEWREL_TSR</td>
        <td>Number of new and relapse TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of new and relapse TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ZFd8LiJ1y3C</td>
        <td>TB - Health facilities with GeneXpert cartridges stock-out days (%)</td>
        <td>HF with GeneXpert cartridges SO days (%)</td>
        <td>HF_WITH_GENEXPERT_CARTRIDGES_STOCKOUT_DAYS_%</td>
        <td>Proportion of health facilities with GeneXpert cartridges stockout days</td>
        <td>HF with GeneXpert cartridges stockout days</td>
        <td>HF reporting stockout days</td>
        <td>Percentage</td>
        <td>2021-06-10</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>zw1DhQYN9mb</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
        <td>5-14 (%) </td>
        <td>TB_C_PCNT_514</td>
        <td></td>
        <td>Number of TB cases aged 5-14 (new and relapse only)</td>
        <td>Total number notified TB cases by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>zyyolGvDOLQ</td>
        <td>TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
        <td>25-34 (%) </td>
        <td>TB_C_PCNT_2534</td>
        <td></td>
        <td>Number of TB cases aged 25-34 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ZZiJYBFEJ3v</td>
        <td>TB - DS-TB drugs redistributed</td>
        <td>DS-TB drugs redistributed</td>
        <td>TB_DSDRUGS_REDISTRIBUTED</td>
        <td>Number of DS-TB drugs redistributed</td>
        <td>TB - DS-TB drugs redistributed</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
    </table>
    <h2 id="indicatorTypes">Indicator types</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Factor</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Per 100 000</td>
        <td>100000</td>
        <td>2021-02-08</td>
        <td>BY11PjGMCg2</td>
      </tr>
      <tr>
        <td>Percentage</td>
        <td>100</td>
        <td>2021-02-08</td>
        <td>hmSnCXmLYwt</td>
      </tr>
      <tr>
        <td>Rate (factor=1)</td>
        <td>1</td>
        <td>2021-02-08</td>
        <td>k4RGC3sMTzO</td>
      </tr>
      <tr>
        <td>Numerator only (number)</td>
        <td>1</td>
        <td>2021-02-08</td>
        <td>kHy61PbChXr</td>
      </tr>
    </table>
    <h2 id="dashboards">Dashboards</h2>
    <h3>TB1. Notifications (numbers) (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB1. Notifications (numbers) (annual)</td>
        <td>2021-02-08</td>
        <td>BwYHhBSvLNL</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>LguXYuBEmNQ</td>
        <td>LINE</td>
        <td>TBc_1.1_TB notifications (annual)</td>
        <td>nz9eRv4twT1</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td>VBUUGBP8RFn</td>
        <td>COLUMN</td>
        <td>TBc_1.2_New and relapse cases by age group and sex (annual)</td>
        <td>qA3xecK9d3N</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td>aMrO2iGluMw</td>
        <td>LINE</td>
        <td>TBc_1.3_New and relapse cases by age group (%) (annual)</td>
        <td>Id0MtXmYnGx</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td>kVt5sqalZ0t</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_1.1_TB notifications (annual)</td>
        <td>Obwiyggbku7</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>YXE5JC3UA7M</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
    </table>
    <h3>TB6. TB/HIV</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB6. TB/HIV</td>
        <td>2021-02-08</td>
        <td>CKcF4jgN0hK</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>SlEHkRsqvAC</td>
        <td>LINE</td>
        <td>TBc_6.1_TB/HIV</td>
        <td>shr7LMtM8On</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>OhyeSu7q7iz</td>
        <td>COLUMN</td>
        <td>TBc_6.2_TB/HIV cascade of care</td>
        <td>p2EP63TQ7Lq</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>LrUYQgoxjjU</td>
        <td>LINE</td>
        <td>TBc_6.3_TB/HIV (%)</td>
        <td>DbwBROfurIz</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>YhP2FYWUnHK</td>
        <td>LINE</td>
        <td>TBc_6.4_Treatment for TB/HIV (%)</td>
        <td>mzHx1LaqrMU</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>d1zWxOwUYd4</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>eef3jlqOLg1</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>D6D3bTBJ61k</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>yD0PNNPCIug</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>MovAqKdNJ8g</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.1_TB/HIV</td>
        <td>xbJbi0G9gVj</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>n6ZXdAl1sfD</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome</td>
        <td>k2RE10PJ1UR</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
    </table>
    <h3>TB4. Outcomes (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB4. Outcomes (annual)</td>
        <td>2021-02-08</td>
        <td>dp6xqlPGxbA</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>MtQa13mO6rU</td>
        <td>LINE</td>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%) (annual)</td>
        <td>jZ8cWjx2Zly</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>lHQXAQohz06</td>
        <td>LINE</td>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB (annual)</td>
        <td>z81FhoG0C5W</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>F5XKTZVRiTS</td>
        <td>STACKED_COLUMN</td>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%) (annual)</td>
        <td>fk7Y6sY2iOG</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>irZRk20Tenx</td>
        <td>LINE</td>
        <td>TBc_4.4_TB treatment success rate for DS and DR-TB (%) (annual)</td>
        <td>GI8KHAj0uJo</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>GoxKhw01VL4</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>QEUxuaZkHtJ</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>m4ZXrCYaJSQ</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>MMVRvraY3Sv</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>WqjHS2fujHP</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%) (annual)</td>
        <td>QyqAwI0jtUQ</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
    </table>
    <h3>TB Stock</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB Stock</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>CM2PcEqCR9o</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>KqDxs3fV59E</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>mBvN5C7NCJ4</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>nSDMgCmJIuY</td>
        <td>PIVOT_TABLE</td>
        <td>TB - GenExpert Cartridges stock status</td>
        <td>V8tZEe2ARAM</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>zYQMT6pnu9V</td>
        <td>PIVOT_TABLE</td>
        <td>TB - GenExpert Cartridges stock discrepancy</td>
        <td>JIKtXlBXXtz</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>anxaaxDVh9I</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>VjMcZMgOVmC</td>
        <td>STACKED_AREA</td>
        <td>TB - Proportion of facilities with stockout days for GeneXpert cartridges</td>
        <td>UciKAQatbZe</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>TEXT</td>
        <td></td>
        <td>dLEMpO2i1Z3</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>qjxIL321YEn</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DS-TB drugs stock</td>
        <td>XTRFKHZ2yoi</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>VrMKZcU5a3W</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DS-TB drugs stock discrepancy</td>
        <td>UBj7OZXkZMQ</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>VFnInTDCop9</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>rPbD7zgFdZT</td>
        <td>STACKED_AREA</td>
        <td>TB - Proportion of facilities with stockout days for DS-TB drugs</td>
        <td>LX4EVFrVwqo</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>TEXT</td>
        <td></td>
        <td>b0vGBKCZLCq</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>EMJHKidKuoc</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DR-TB drugs stock discrepancy</td>
        <td>U8U4RonVgtD</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>dsQZNkGSTAc</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DR-TB drugs stock status, last 6 months</td>
        <td>PcPEpYyy0Aj</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>TEXT</td>
        <td></td>
        <td>VlMY2ASTMq8</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>nvXUfRqe14f</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>ZAeLdaLBgjB</td>
        <td>STACKED_AREA</td>
        <td>TB - Proportion of facilities with stockout days for DR-TB drugs</td>
        <td>qcKDsbgk22f</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
    </table>
    <h3>TB3. Notifications (% and ratios)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB3. Notifications (% and ratios)</td>
        <td>2021-02-08</td>
        <td>if78tRW7B91</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>NoiUFmU3mwj</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range)</td>
        <td>dI0BuQ22mrU</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>mwZFo4vmMOW</td>
        <td>LINE</td>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%)</td>
        <td>I8JfSmcBEAW</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>ZFF0EYzSHTu</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>UbDvCPn6lA4</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>QyQzm2GQCzQ</td>
        <td>LINE</td>
        <td>TBc_3.2_Previously treated among all TB cases (%)</td>
        <td>f46K4CdFW4j</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>NAjbRucsu2k</td>
        <td>LINE</td>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases</td>
        <td>BOWxnLBWwwC</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>tby2zeoJvAn</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>FkxqwYT02FH</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>H4ZogkYjAKR</td>
        <td>LINE</td>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%)</td>
        <td>fPuLv2sFO7Y</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>ZheCuN6QKui</td>
        <td>LINE</td>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse</td>
        <td>eF7XzWNAg07</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>EkVn7xbGCZ1</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>FvXSHrTso6M</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>GL1rmJsVIax</td>
        <td>LINE</td>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%)</td>
        <td>zbLRuAXW3h3</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>QAM7Kevs5o5</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
    </table>
    <h3>TB6. TB/HIV (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB6. TB/HIV (annual)</td>
        <td>2021-02-08</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>ATqz1kTBfxW</td>
        <td>LINE</td>
        <td>TBc_6.1_TB/HIV (annual)</td>
        <td>OeMcgjmNLMg</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>D92gRVlZ8cU</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>X8UHouVdDjc</td>
        <td>COLUMN</td>
        <td>TBc_6.2_TB/HIV cascade of care (annual)</td>
        <td>ZjaM3EaXzMQ</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>NWjd84JZ9RD</td>
        <td>LINE</td>
        <td>TBc_6.3_TB/HIV (%) (annual)</td>
        <td>cyoKklhDNSY</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>FTbVCFB10Vn</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>nP0q23XggJq</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>ogUmIuGstD3</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>fnMFUxmPG8Y</td>
        <td>LINE</td>
        <td>TBc_6.4_Treatment for TB/HIV (%) (annual)</td>
        <td>KSV8x7mQjDn</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>T3gUqqzJLsH</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.1_TB/HIV (annual)</td>
        <td>XoCshygFgWg</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>hQ1ksBSIpQr</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome (annual)</td>
        <td>pm7Nn4sPr7L</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
    </table>
    <h3>TB3. Notifications (% and ratios) (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB3. Notifications (% and ratios) (annual)</td>
        <td>2021-02-08</td>
        <td>MaJqTSteIqg</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>o0FulK7B5Tm</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range) (annual)</td>
        <td>LJBavF0oh1a</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>cnmGWqRdu7f</td>
        <td>LINE</td>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%) (annual)</td>
        <td>OuYa4mQbFIh</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>qSKpXi8CYbH</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>cJhZEudYmCB</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>y1PsykoX8yk</td>
        <td>LINE</td>
        <td>TBc_3.2_Previously treated among all TB cases (%) (annual)</td>
        <td>qHIIthzUTFP</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>n88jd53fqYz</td>
        <td>LINE</td>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases (annual)</td>
        <td>Js28yhoExGv</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>EJUIt79AFdp</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>UwIuXB0ru0y</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>m4E9SYCJGk8</td>
        <td>LINE</td>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%) (annual)</td>
        <td>E0P6FWkCHIj</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>sdrEn6gVLwu</td>
        <td>LINE</td>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse (annual)</td>
        <td>pVqPr1L2DIe</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>WQY9oYmPqPy</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>rJq63vCI4xP</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>n5RtZTSpSMB</td>
        <td>LINE</td>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%) (annual)</td>
        <td>Uc7hVulDfzT</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>Q2IMp2skRDR</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
    </table>
    <h3>TB4. Outcomes</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB4. Outcomes</td>
        <td>2021-02-08</td>
        <td>pZXvrpebwFT</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>xNUAsk6iKWN</td>
        <td>LINE</td>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%)</td>
        <td>IJuEfo4RKjs</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>N6g3WrsvWgi</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td>z4sqramOZ2O</td>
        <td>LINE</td>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB</td>
        <td>AvEoJBCGSEc</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td>QviEQL6VIGG</td>
        <td>STACKED_COLUMN</td>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%)</td>
        <td>aQ7X6BPuvCG</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>LlMoGm1BcKv</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>HhAX7geBGGQ</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>kjEE275wD6L</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td>QpBF8PgtqCo</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%)</td>
        <td>zhklAZMSeCv</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
    </table>
    <h3>TB2. Notifications (rates) (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB2. Notifications (rates) (annual)</td>
        <td>2021-02-08</td>
        <td>VtRtBqorLfR</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>flmCSE02H0L</td>
        <td>LINE</td>
        <td>TBc_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td>IhRXuXlSqcX</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>pnm1O5xvHcu</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td>RebWOM2dwTr</td>
        <td>LINE</td>
        <td>TBc_2.2_Population</td>
        <td>SMesP19mefY</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>abS1intHRTr</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td>yme39V6fjq2</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td>KT41iiQUfPh</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
    </table>
    <h3>TB1. Notifications (numbers)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB1. Notifications (numbers)</td>
        <td>2021-02-08</td>
        <td>w48LnY9Gamc</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>dqXV24zjpab</td>
        <td>LINE</td>
        <td>TBc_1.1_TB notifications</td>
        <td>yZG9zAC6JHB</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td>TfeoSE7Ha8F</td>
        <td>COLUMN</td>
        <td>TBc_1.2_New and relapse cases by age group and sex</td>
        <td>wEXmZGyxdS9</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td>xZzgm1PhIUN</td>
        <td>LINE</td>
        <td>TBc_1.3_New and relapse cases by age group (%)</td>
        <td>nHn8Wyfvrng</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>iKxZ7HyjjC1</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td>ByQmGVlO9GY</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_1.1_TB notifications</td>
        <td>Ht3oOsFNYsg</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
    </table>
    <h3>TB5. DR-TB (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB5. DR-TB (annual)</td>
        <td>2021-02-08</td>
        <td>xJXvUOEhnE9</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>Fw0CsA5Dpvf</td>
        <td>STACKED_COLUMN</td>
        <td>TBc_5.5_Treatment outcomes for DR-TB (%) (annual)</td>
        <td>bUWDwyerBIa</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>ag7ePsZlVv3</td>
        <td>COLUMN</td>
        <td>TBc_5.1_Cascade of care for RR/MDR-TB (annual)</td>
        <td>CBAqS2I0Nyf</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>giHwCjbaeHp</td>
        <td>LINE</td>
        <td>TBc_5.2_Drug susceptibility testing (DST) coverage for TB cases (%) (annual)</td>
        <td>Id2NdYsksAS</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>aW6QKbEDCY7</td>
        <td>LINE</td>
        <td>TBc_5.3_TB cases with laboratory confirmed RR/MDR-TB (%) (annual)</td>
        <td>HEWA7fJ7eIh</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>rd4XoF2W92u</td>
        <td>LINE</td>
        <td>TBc_5.4_Laboratory-confirmed RR/MDR-TB cases started MDR treatment (%) (annual)</td>
        <td>gyDj0nK4eOF</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>hox3ExUTOAJ</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_5.1_Drug resistance TB (annual)</td>
        <td>NlLftHwaxDS</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
    </table>
    <h2 id="visualizations">Visualizations</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Description</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TBc_4.3b_Treatment outcomes for previously treated DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>A3sd6M0Ar3A</td>
      </tr>
      <tr>
        <td>TBc_5.1_Cascade of care for RR/MDR-TB (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ag7ePsZlVv3</td>
      </tr>
      <tr>
        <td>TBc_1.3_New and relapse cases by age group (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>aMrO2iGluMw</td>
      </tr>
      <tr>
        <td>TBc_6.1_TB/HIV (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ATqz1kTBfxW</td>
      </tr>
      <tr>
        <td>TBc_5.3_TB cases with laboratory confirmed RR/MDR-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>aW6QKbEDCY7</td>
      </tr>
      <tr>
        <td>TBc_1.2a_New smear positive by age group and sex (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>b8BvZ2yyAGI</td>
      </tr>
      <tr>
        <td>TBc_6.2b_TB/HIV cascade of care (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>BSKSZRKbSUU</td>
      </tr>
      <tr>
        <td>TBt_1.1_TB notifications</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ByQmGVlO9GY</td>
      </tr>
      <tr>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>cnmGWqRdu7f</td>
      </tr>
      <tr>
        <td>TBc_6.2c_TB/HIV cascade of care (all cases) (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>cS2kUPAkWri</td>
      </tr>
      <tr>
        <td>TBc_4.3a_Treatment outcomes for DS-TB/HIV (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>cT3HLHVOOwF</td>
      </tr>
      <tr>
        <td>TBt_0.2_Treatment outcomes_all data elements_annual</td>
        <td>to export data elements for treatment outcomes (sub-national level)</td>
        <td>2021-02-08</td>
        <td>dQxhOVtwwK8</td>
      </tr>
      <tr>
        <td>TBc_1.1_TB notifications</td>
        <td></td>
        <td>2021-02-08</td>
        <td>dqXV24zjpab</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock status, last 6 months</td>
        <td></td>
        <td>2021-04-29</td>
        <td>dsQZNkGSTAc</td>
      </tr>
      <tr>
        <td>TBc_6.2b_TB/HIV cascade of care (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>dXIKcGcRfC4</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock discrepancy</td>
        <td></td>
        <td>2021-04-29</td>
        <td>EMJHKidKuoc</td>
      </tr>
      <tr>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>F5XKTZVRiTS</td>
      </tr>
      <tr>
        <td>TBc_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>flmCSE02H0L</td>
      </tr>
      <tr>
        <td>TBc_6.4_Treatment for TB/HIV (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>fnMFUxmPG8Y</td>
      </tr>
      <tr>
        <td>TBc_5.5_Treatment outcomes for DR-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>Fw0CsA5Dpvf</td>
      </tr>
      <tr>
        <td>TBc_5.2_Drug susceptibility testing (DST) coverage for TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>giHwCjbaeHp</td>
      </tr>
      <tr>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>GL1rmJsVIax</td>
      </tr>
      <tr>
        <td>TBc_6.2a_TB/HIV cascade of care (all cases) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>gOYlLJb51tn</td>
      </tr>
      <tr>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>H4ZogkYjAKR</td>
      </tr>
      <tr>
        <td>TBt_5.1_Drug resistance TB (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>hox3ExUTOAJ</td>
      </tr>
      <tr>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome (annual)</td>
        <td>Comparison of TB/HIV data recorded at the time of case notification and data recorded at the time of treatment outcome</td>
        <td>2021-02-08</td>
        <td>hQ1ksBSIpQr</td>
      </tr>
      <tr>
        <td>TBc_4.4_TB treatment success rate for DS and DR-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>irZRk20Tenx</td>
      </tr>
      <tr>
        <td>TBt_1.1_TB notifications (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>kVt5sqalZ0t</td>
      </tr>
      <tr>
        <td>TBc_1.1_TB notifications (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>LguXYuBEmNQ</td>
      </tr>
      <tr>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>lHQXAQohz06</td>
      </tr>
      <tr>
        <td>TBc_6.3_TB/HIV (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>LrUYQgoxjjU</td>
      </tr>
      <tr>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>m4E9SYCJGk8</td>
      </tr>
      <tr>
        <td>TBt_6.1_TB/HIV</td>
        <td></td>
        <td>2021-02-08</td>
        <td>MovAqKdNJ8g</td>
      </tr>
      <tr>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>MtQa13mO6rU</td>
      </tr>
      <tr>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>mwZFo4vmMOW</td>
      </tr>
      <tr>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>n5RtZTSpSMB</td>
      </tr>
      <tr>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome</td>
        <td>Comparison of TB/HIV data recorded at the time of case notification and data recorded at the time of treatment outcome</td>
        <td>2021-02-08</td>
        <td>n6ZXdAl1sfD</td>
      </tr>
      <tr>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>n88jd53fqYz</td>
      </tr>
      <tr>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NAjbRucsu2k</td>
      </tr>
      <tr>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NoiUFmU3mwj</td>
      </tr>
      <tr>
        <td>TBc_1.3a_New cases (all forms) by age group (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NpBI7jrzA0z</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges stock status</td>
        <td></td>
        <td>2021-04-29</td>
        <td>nSDMgCmJIuY</td>
      </tr>
      <tr>
        <td>TBc_6.3_TB/HIV (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NWjd84JZ9RD</td>
      </tr>
      <tr>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>o0FulK7B5Tm</td>
      </tr>
      <tr>
        <td>TBc_6.3a_TB/HIV – all TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>obyjcDqxXls</td>
      </tr>
      <tr>
        <td>TBc_6.2_TB/HIV cascade of care</td>
        <td></td>
        <td>2021-02-08</td>
        <td>OhyeSu7q7iz</td>
      </tr>
      <tr>
        <td>TBc_4.3e_Treatment outcomes for smear positive DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ORUu9PBi84b</td>
      </tr>
      <tr>
        <td>TBc_4.3a_Treatment outcomes for DS-TB/HIV (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>q9Tag5rbuDJ</td>
      </tr>
      <tr>
        <td>TBc_4.3d_Treatment outcomes for bacteriologically confirmed DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>qjAxCdXK4it</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock</td>
        <td></td>
        <td>2021-04-29</td>
        <td>qjxIL321YEn</td>
      </tr>
      <tr>
        <td>TBc_6.2c_TB/HIV cascade of care (all cases) (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>qmmhMtrCtby</td>
      </tr>
      <tr>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QpBF8PgtqCo</td>
      </tr>
      <tr>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QviEQL6VIGG</td>
      </tr>
      <tr>
        <td>TBc_3.2_Previously treated among all TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QyQzm2GQCzQ</td>
      </tr>
      <tr>
        <td>TBc_5.4_Laboratory-confirmed RR/MDR-TB cases started MDR treatment (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>rd4XoF2W92u</td>
      </tr>
      <tr>
        <td>TBc_2.2_Population</td>
        <td></td>
        <td>2021-02-08</td>
        <td>RebWOM2dwTr</td>
      </tr>
      <tr>
        <td>TB - Proportion of facilities with stockout days for DS-TB drugs</td>
        <td></td>
        <td>2021-04-29</td>
        <td>rPbD7zgFdZT</td>
      </tr>
      <tr>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>sdrEn6gVLwu</td>
      </tr>
      <tr>
        <td>TBc_6.1_TB/HIV</td>
        <td></td>
        <td>2021-02-08</td>
        <td>SlEHkRsqvAC</td>
      </tr>
      <tr>
        <td>TBt_0.1_Notifications_all data elements_annual</td>
        <td>to export all data elements for TB case notifications (sub-national level) </td>
        <td>2021-02-08</td>
        <td>StXxQoaz26k</td>
      </tr>
      <tr>
        <td>TBt_6.1_TB/HIV (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>T3gUqqzJLsH</td>
      </tr>
      <tr>
        <td>TBc_1.2_New and relapse cases by age group and sex</td>
        <td></td>
        <td>2021-02-08</td>
        <td>TfeoSE7Ha8F</td>
      </tr>
      <tr>
        <td>TBc_4.3b_Treatment outcomes for previously treated DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>UHn8QRtiKGH</td>
      </tr>
      <tr>
        <td>TBc_1.2_New and relapse cases by age group and sex (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>VBUUGBP8RFn</td>
      </tr>
      <tr>
        <td>TB - Proportion of facilities with stockout days for GeneXpert cartridges</td>
        <td></td>
        <td>2021-04-29</td>
        <td>VjMcZMgOVmC</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock discrepancy</td>
        <td></td>
        <td>2021-04-29</td>
        <td>VrMKZcU5a3W</td>
      </tr>
      <tr>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>WqjHS2fujHP</td>
      </tr>
      <tr>
        <td>TBc_6.2_TB/HIV cascade of care (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>X8UHouVdDjc</td>
      </tr>
      <tr>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>xNUAsk6iKWN</td>
      </tr>
      <tr>
        <td>TBc_6.3a_TB/HIV – all TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>xpiCsSSLVXp</td>
      </tr>
      <tr>
        <td>TBc_1.3_New and relapse cases by age group (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>xZzgm1PhIUN</td>
      </tr>
      <tr>
        <td>TBc_3.2_Previously treated among all TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>y1PsykoX8yk</td>
      </tr>
      <tr>
        <td>TBc_6.4_Treatment for TB/HIV (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>YhP2FYWUnHK</td>
      </tr>
      <tr>
        <td>TBt_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>yme39V6fjq2</td>
      </tr>
      <tr>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB</td>
        <td></td>
        <td>2021-02-08</td>
        <td>z4sqramOZ2O</td>
      </tr>
      <tr>
        <td>TB - Proportion of facilities with stockout days for DR-TB drugs</td>
        <td></td>
        <td>2021-04-29</td>
        <td>ZAeLdaLBgjB</td>
      </tr>
      <tr>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ZheCuN6QKui</td>
      </tr>
      <tr>
        <td>TBc_6.2a_TB/HIV cascade of care (all cases)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ztsp2Ew6kdN</td>
      </tr>
      <tr>
        <td>TBc_1.3b_New smear positive cases by age group (0-14 group) (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>zvXhppFsdjd</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges stock discrepancy</td>
        <td></td>
        <td>2021-04-29</td>
        <td>zYQMT6pnu9V</td>
      </tr>
    </table>
    <h2 id="maps">Maps</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Description</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TBm_4.2_Died among DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>AMHFI7PpJO5</td>
      </tr>
      <tr>
        <td>TB - Coverage time for DS-TB drugs by facility</td>
        <td> </td>
        <td>2021-05-03</td>
        <td>b1Q7LZBMulY</td>
      </tr>
      <tr>
        <td>TBm_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>b6VznqkP4Hc</td>
      </tr>
      <tr>
        <td>TBm_3.2_Previously treated among all TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>B9OHkT2S5Xj</td>
      </tr>
      <tr>
        <td>TBm_3.3_Ratio of male:female in new and relapse TB cases (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>DgdlRnHuE0A</td>
      </tr>
      <tr>
        <td>TBm_3.7_Bacteriologically confirmed among previously treated (incl. rel) pulmonary TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>Eq9lKUQOykM</td>
      </tr>
      <tr>
        <td>TB - Facilities with stockout days for GeneXpert cartridges</td>
        <td> </td>
        <td>2021-04-30</td>
        <td>eYZd1BLeELf</td>
      </tr>
      <tr>
        <td>TB - Facilities with stockout days for DR-TB drugs</td>
        <td> </td>
        <td>2021-04-29</td>
        <td>f51qX1C56dW</td>
      </tr>
      <tr>
        <td>TBm_3.7_Bacteriologically confirmed among previously treated (incl. rel) pulmonary TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>HFi8Oy2fFdJ</td>
      </tr>
      <tr>
        <td>TBm_4.4_Not evaluated among DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>HtWmQvq3Big</td>
      </tr>
      <tr>
        <td>TBm_6.1a_All TB cases with known HIV status (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ICV9ugEX8hT</td>
      </tr>
      <tr>
        <td>TBm_4.3_Lost to follow up among DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>IvX8f4BVdep</td>
      </tr>
      <tr>
        <td>TBm_6.2_TB/HIV positive cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>j8zUgUmQFZf</td>
      </tr>
      <tr>
        <td>TBm_3.4_0-14 year olds among new and relapse TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>JCOu5xpYab7</td>
      </tr>
      <tr>
        <td>TBm_6.4_TB/HIV positive cases on ART (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>Jml9eHAea4a</td>
      </tr>
      <tr>
        <td>TBm_4.1_TB treatment success rate for DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>JunQVZF5CRT</td>
      </tr>
      <tr>
        <td>TB - Facilities with stockout days for DS-TB drugs</td>
        <td> </td>
        <td>2021-04-29</td>
        <td>LDSu7bMS2Kl</td>
      </tr>
      <tr>
        <td>TBm_3.4_0-14 year olds among new and relapse TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ldttHHBp997</td>
      </tr>
      <tr>
        <td>TBm_4.1_TB treatment success rate for DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>LyVmrWtEG89</td>
      </tr>
      <tr>
        <td>TBm_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>nwpHvLnBA9k</td>
      </tr>
      <tr>
        <td>TBm_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>oA74TkHOKnX</td>
      </tr>
      <tr>
        <td>TBm_6.1_TB cases with known HIV status (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>owinxzHtr0A</td>
      </tr>
      <tr>
        <td>TBm_6.1_TB cases with known HIV status (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>P7av1zZyFUF</td>
      </tr>
      <tr>
        <td>TBm_6.1a_All TB cases with known HIV status (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>R2kLLio5dEv</td>
      </tr>
      <tr>
        <td>TBm_4.3_Lost to follow up among DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>rJsFxDgQYVj</td>
      </tr>
      <tr>
        <td>TB - Coverage time for GeneXpert cartridges by facility</td>
        <td> </td>
        <td>2021-04-30</td>
        <td>RnpweIAT2Vp</td>
      </tr>
      <tr>
        <td>TBm_3.2_Previously treated among all TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>SscfJywlazw</td>
      </tr>
      <tr>
        <td>TBm_4.2_Died among DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>tkxvwRtZerK</td>
      </tr>
      <tr>
        <td>TBm_6.3_TB/HIV positive cases</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>TlTNSdMHKmh</td>
      </tr>
      <tr>
        <td>TBm_6.3_TB/HIV positive cases (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>U6sHkqmq1Fb</td>
      </tr>
      <tr>
        <td>TBm_3.6_Bacteriologically confirmed among all pulmonary TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ueZ62zNlFku</td>
      </tr>
      <tr>
        <td>TBm_6.2_TB/HIV positive cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>UI7LwLu8g36</td>
      </tr>
      <tr>
        <td>TBm_6.4_TB/HIV positive cases on ART (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>UOxCDyo3OAw</td>
      </tr>
      <tr>
        <td>TBm_1.1_Notified TB cases (new and relapse, all forms)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>VlwvfmQwK6w</td>
      </tr>
      <tr>
        <td>TBm_3.1_Extrapulmonary among new TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>vmbo6abJkSX</td>
      </tr>
      <tr>
        <td>TBm_3.6_Bacteriologically confirmed among all pulmonary TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>WBJLfr4wqn1</td>
      </tr>
      <tr>
        <td>TBm_1.1_Notified TB cases (new and relapse, all forms)(annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>WPvRBVgIYkG</td>
      </tr>
      <tr>
        <td>TBm_3.1_Extrapulmonary among new TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ws2oWQsS755</td>
      </tr>
      <tr>
        <td>TBm_3.3_Ratio of male:female in new and relapse TB cases</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>XMV8asb1Vw0</td>
      </tr>
      <tr>
        <td>TB - Coverage time for DR-TB drugs by facility</td>
        <td> </td>
        <td>2021-05-03</td>
        <td>Y2rQpAz7UMa</td>
      </tr>
      <tr>
        <td>TBm_2.2_Population</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>yuVAwEOE8Ou</td>
      </tr>
      <tr>
        <td>TBm_4.4_Not evaluated among DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ZRCWpzVonSZ</td>
      </tr>
    </table>
    <h2 id="reports">Standard reports</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Compare subunits using the same graph/Comparez les sous-unités utilisant le même graphique</td>
        <td>2021-03-03</td>
        <td>BuTAAbV4zMg</td>
      </tr>
    </table>
    <h2 id="legendSets">Legend Sets</h2>
    <h3>Legend_TBm_3.6</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.6</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>AZLl9cQBN4T</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>80 - 100</td>
        <td>80</td>
        <td>100</td>
        <td>2018-08-22</td>
        <td>RHfEO1vcqc6</td>
      </tr>
      <tr>
        <td>60 - 80</td>
        <td>60</td>
        <td>80</td>
        <td>2018-08-22</td>
        <td>JRYnl6RbBWQ</td>
      </tr>
      <tr>
        <td>40 - 60</td>
        <td>40</td>
        <td>60</td>
        <td>2018-08-22</td>
        <td>Sa4708TG8qf</td>
      </tr>
      <tr>
        <td>20 - 40</td>
        <td>20</td>
        <td>40</td>
        <td>2018-08-22</td>
        <td>WA71IIb4Hyu</td>
      </tr>
      <tr>
        <td>0 - 20</td>
        <td>0</td>
        <td>20</td>
        <td>2018-08-22</td>
        <td>vc91HEcRlln</td>
      </tr>
    </table>
    <h3>Legend_TBm_2.1_TB notification rate</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_2.1_TB notification rate</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>bvsTaKBeBJr</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>300 +</td>
        <td>300</td>
        <td>2000</td>
        <td>2018-06-28</td>
        <td>Ov7aA8TPlFM</td>
      </tr>
      <tr>
        <td>200 - 300</td>
        <td>200</td>
        <td>300</td>
        <td>2018-06-28</td>
        <td>EdoKNBlMRjT</td>
      </tr>
      <tr>
        <td>100 - 200</td>
        <td>100</td>
        <td>200</td>
        <td>2018-06-28</td>
        <td>KDRQ5wgWeH8</td>
      </tr>
      <tr>
        <td>75 - 100</td>
        <td>75</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>NcptBWd0mER</td>
      </tr>
      <tr>
        <td>50 - 75</td>
        <td>50</td>
        <td>75</td>
        <td>2018-06-28</td>
        <td>cVbnXKvjmS3</td>
      </tr>
      <tr>
        <td>25 - 50</td>
        <td>25</td>
        <td>50</td>
        <td>2018-06-28</td>
        <td>XNnRpwmHDJH</td>
      </tr>
      <tr>
        <td>0 - 25</td>
        <td>0.01</td>
        <td>25</td>
        <td>2018-06-28</td>
        <td>VIbwsXYwf6o</td>
      </tr>
      <tr>
        <td>0</td>
        <td>0</td>
        <td>0.01</td>
        <td>2018-06-28</td>
        <td>kxGOEkgAkQh</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.3_Ratio male:female</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.3_Ratio male:female</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>c2WmhDERIo9</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 2</td>
        <td>2</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>HwDUqKYklZg</td>
      </tr>
      <tr>
        <td>1</td>
        <td>1</td>
        <td>1</td>
        <td>2018-06-28</td>
        <td>O7iJon3zqgA</td>
      </tr>
      <tr>
        <td>1-2</td>
        <td>1</td>
        <td>2</td>
        <td>2018-06-28</td>
        <td>YwboYL7y0lR</td>
      </tr>
      <tr>
        <td>0.5-1</td>
        <td>0.5</td>
        <td>1</td>
        <td>2018-06-28</td>
        <td>a0uC3QxlzJp</td>
      </tr>
      <tr>
        <td>
          < 0.5</td>
        <td>0</td>
        <td>0.5</td>
        <td>2018-06-28</td>
        <td>rrprM8Ddds3</td>
      </tr>
    </table>
    <h3>Legend_TBt_3.1_Children (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBt_3.1_Children (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>eKcBht0c5OQ</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>15 - 100</td>
        <td>15</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>X03rO8hw7n2</td>
      </tr>
      <tr>
        <td>5-15</td>
        <td>5</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>nL5uBMartNu</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>CStbLXkDyI6</td>
      </tr>
    </table>
    <h3>Stock coverage time</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Stock coverage time</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-04-30</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>f1hWZIYCTzc</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Invalid</td>
        <td>12</td>
        <td>200</td>
        <td>2021-04-30</td>
        <td>wfbGANgbnMR</td>
      </tr>
      <tr>
        <td>Overstock</td>
        <td>3</td>
        <td>12</td>
        <td>2021-04-30</td>
        <td>ee8QJxth4ul</td>
      </tr>
      <tr>
        <td>Adequate stock</td>
        <td>1</td>
        <td>3</td>
        <td>2021-04-30</td>
        <td>mmvDbIcm41d</td>
      </tr>
      <tr>
        <td>Understock</td>
        <td>0.0001</td>
        <td>1</td>
        <td>2021-04-30</td>
        <td>wAdm1fy3Fmk</td>
      </tr>
      <tr>
        <td>Stock out</td>
        <td>0</td>
        <td>0.0001</td>
        <td>2021-04-30</td>
        <td>fFBIEwglorN</td>
      </tr>
    </table>
    <h3>Legend_TBt_3.1_Ratio 0-4:5-14</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBt_3.1_Ratio 0-4:5-14</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>gLSVwEvgfnM</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>3 - 100</td>
        <td>3</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>CeDN48v2HMJ</td>
      </tr>
      <tr>
        <td>1.5 - 3</td>
        <td>1.5</td>
        <td>3</td>
        <td>2018-06-28</td>
        <td>uwQfapDxDjH</td>
      </tr>
      <tr>
        <td>0 - 1.5</td>
        <td>0</td>
        <td>1.5</td>
        <td>2018-06-28</td>
        <td>V3aBpzhvkE9</td>
      </tr>
    </table>
    <h3>Legend_TBm_6.1_TB/HIV tested (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_6.1_TB/HIV tested (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>kgDM8HYbyOr</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 80</td>
        <td>80</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>jJGbzlsli40</td>
      </tr>
      <tr>
        <td>60 - 80</td>
        <td>60</td>
        <td>80</td>
        <td>2018-05-29</td>
        <td>or4xT4wLIOh</td>
      </tr>
      <tr>
        <td>40 - 60</td>
        <td>40</td>
        <td>60</td>
        <td>2018-05-29</td>
        <td>dySuXqQdQhz</td>
      </tr>
      <tr>
        <td>20 - 40</td>
        <td>20</td>
        <td>40</td>
        <td>2018-05-29</td>
        <td>GZ3ihJU1VUQ</td>
      </tr>
      <tr>
        <td>0 - 20</td>
        <td>0</td>
        <td>20</td>
        <td>2018-05-29</td>
        <td>DzvgreGlT6r</td>
      </tr>
    </table>
    <h3>Legend_TBm_6.4_TB/HIV on ART (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_6.4_TB/HIV on ART (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>LHfQrsmoMOB</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>75 - 100</td>
        <td>75</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>T7vRYnCgOdr</td>
      </tr>
      <tr>
        <td>50 - 75</td>
        <td>50</td>
        <td>75</td>
        <td>2018-06-28</td>
        <td>B4aPjoBS7gm</td>
      </tr>
      <tr>
        <td>25 - 50</td>
        <td>25</td>
        <td>50</td>
        <td>2018-06-28</td>
        <td>BjG951vEcqj</td>
      </tr>
      <tr>
        <td>0 - 25</td>
        <td>0</td>
        <td>25</td>
        <td>2018-06-28</td>
        <td>qpv2Wgfgvzq</td>
      </tr>
    </table>
    <h3>Legend_TBm_4.1_Tx success rate (all DS-TB) (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_4.1_Tx success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>mkOwPv9yAsr</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>90 - 100</td>
        <td>90</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>nWPtWz6STqn</td>
      </tr>
      <tr>
        <td>80 - 90</td>
        <td>80</td>
        <td>90</td>
        <td>2018-05-29</td>
        <td>EdNvsRg9Oxv</td>
      </tr>
      <tr>
        <td>50 - 80</td>
        <td>50</td>
        <td>80</td>
        <td>2018-05-29</td>
        <td>BUP3WbzqwSC</td>
      </tr>
      <tr>
        <td>20 - 50</td>
        <td>20</td>
        <td>50</td>
        <td>2018-05-29</td>
        <td>oNciUbh8Rhp</td>
      </tr>
      <tr>
        <td>0 - 20</td>
        <td>0</td>
        <td>20</td>
        <td>2018-05-29</td>
        <td>HgOxsev9XT0</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.2_Previously treated (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.2_Previously treated (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>nyybajrEibI</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 20</td>
        <td>20</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>m3I1Bm3Kx3i</td>
      </tr>
      <tr>
        <td>10 - 20</td>
        <td>10</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>JWxM9tlG8uC</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-06-28</td>
        <td>grNxIkz6bQt</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>c1zdJAbzmPH</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.1_New extrapulmonary (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.1_New extrapulmonary (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>PNIsr3txKyc</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>≥ 30</td>
        <td>30</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>beKL24FwPTP</td>
      </tr>
      <tr>
        <td>20 - 30</td>
        <td>20</td>
        <td>30</td>
        <td>2018-06-28</td>
        <td>aZmoQaM7GNa</td>
      </tr>
      <tr>
        <td>15 - 20</td>
        <td>15</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>oUIZC6aGnCn</td>
      </tr>
      <tr>
        <td>10 - 15</td>
        <td>10</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>gHeuRjDITWT</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-06-28</td>
        <td>FTmkA7TXDsj</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>ztDmjmHu5pP</td>
      </tr>
    </table>
    <h3>Stock discrepancy</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Stock discrepancy</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-05-11</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>pxeFezcPnQl</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Positive</td>
        <td>9</td>
        <td>10000000</td>
        <td>2021-05-11</td>
        <td>IdLVcKSBYPP</td>
      </tr>
      <tr>
        <td>Correct stock</td>
        <td>1</td>
        <td>9</td>
        <td>2021-05-11</td>
        <td>bW5lmAtDMhX</td>
      </tr>
      <tr>
        <td>Negative</td>
        <td>-10000000</td>
        <td>1</td>
        <td>2021-05-11</td>
        <td>EcNjRnWM0Yw</td>
      </tr>
    </table>
    <h3>xxx Population (total)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>xxx Population (total)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>RcEA84L909S</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>800000 - 1000000</td>
        <td>800000</td>
        <td>1000000</td>
        <td>2018-05-29</td>
        <td>EFVLtD05wMB</td>
      </tr>
      <tr>
        <td>600000 - 800000</td>
        <td>600000</td>
        <td>800000</td>
        <td>2018-05-29</td>
        <td>Qq7qzjYS0Yd</td>
      </tr>
      <tr>
        <td>400000 - 600000</td>
        <td>400000</td>
        <td>600000</td>
        <td>2018-05-29</td>
        <td>ShWS6PHHTuF</td>
      </tr>
      <tr>
        <td>200000 - 400000</td>
        <td>200000</td>
        <td>400000</td>
        <td>2018-05-29</td>
        <td>NYM6D7zGdNS</td>
      </tr>
      <tr>
        <td>0 - 200000</td>
        <td>0</td>
        <td>200000</td>
        <td>2018-05-29</td>
        <td>KUxkOBcYMGJ</td>
      </tr>
    </table>
    <h3>Legend_TBm_4.2-4_Treatment outcomes (died, lost, not evaluated) (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_4.2-4_Treatment outcomes (died, lost, not evaluated) (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>Tqmc5ihvo7W</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 20</td>
        <td>20</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>V3fgUEXqUN6</td>
      </tr>
      <tr>
        <td>10 - 20</td>
        <td>10</td>
        <td>20</td>
        <td>2018-05-29</td>
        <td>zO30gF4ML5O</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-05-29</td>
        <td>IZY14qHwFMq</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-05-29</td>
        <td>Z2MWPGZa2TU</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.4_0-14 year olds (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.4_0-14 year olds (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>uKiwPhS2VjW</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>≥ 15</td>
        <td>15</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>up3VhU6QDqI</td>
      </tr>
      <tr>
        <td>5 - 15</td>
        <td>5</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>eOHaurFcaH8</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>qjN8wBO2fTz</td>
      </tr>
    </table>
    <h3>Legend_TBm_6.2_TB/HIV positive (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_6.2_TB/HIV positive (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>UnokSnIWjqw</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>≥ 30</td>
        <td>30</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>rP9bZc8HbLP</td>
      </tr>
      <tr>
        <td>20 - 30</td>
        <td>20</td>
        <td>30</td>
        <td>2018-06-28</td>
        <td>BQ67g0uz5WB</td>
      </tr>
      <tr>
        <td>15 - 20</td>
        <td>15</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>Zge0Im44ZW7</td>
      </tr>
      <tr>
        <td>10 - 15</td>
        <td>10</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>WgCB94x0ZTH</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-06-28</td>
        <td>LauTfAmIwKz</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>LOtEVAcUXT6</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.5_Ratio 0-4:5-14</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.5_Ratio 0-4:5-14</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>xY9TN26ieF0</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 3</td>
        <td>3</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>aaMYKK85CCR</td>
      </tr>
      <tr>
        <td>1.5 - 3.0</td>
        <td>1.45</td>
        <td>3</td>
        <td>2018-05-29</td>
        <td>cFV2cNkYyB7</td>
      </tr>
      <tr>
        <td>
          < 1.5</td>
        <td>0</td>
        <td>1.45</td>
        <td>2018-05-29</td>
        <td>oihOsZc6ZTA</td>
      </tr>
    </table>
    <h2 id="userGroups">User Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TB access</td>
        <td>2021-05-20</td>
        <td>pyu2ZlNKbzQ</td>
      </tr>
      <tr>
        <td>TB admin</td>
        <td>2021-05-20</td>
        <td>Ubzlyfqm1gO</td>
      </tr>
      <tr>
        <td>TB data capture</td>
        <td>2021-05-20</td>
        <td>UKWx4jJcrKt</td>
      </tr>
    </table>
    <h2>Users</h2>
    <table>
      <tr>
        <th>Username</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>who</td>
        <td>2018-07-13</td>
        <td>vUeLeQMSwhN</td>
      </tr>
    </table>
  </body>

</html>